Home
  >  
Section 35

EurekaMag Full Text Articles Chapter 34,584



References:

Westney, O.L.; Mcguire, E.J. 1999: Circumferential martius urethral wrap with vaginal urethrolysis for recurrent urethral hypersuspension. Journal of Urology 161(4 Suppl): 81
Bone, D.; Eurenius, L.; Niklasson, U.; Von Bibra, H. 2000: Circumferential profile analysis for quantitative comparison of simultaneous pulse inversion and SPECT dipyridamole stress studies of myocardial perfusion. Journal of the American College of Cardiology 35(2 Suppl A): 472A-473A
Yamamoto, I.; Yamamoto, I.; Fujimura, M.; Kinoshita, T.; Hirano, M.; Nishimura, K. 2000: Circumferential projections of myenteric plexus neurons in the guinea-pig small intestine. Regulatory Peptides 94(1-3): 12, 25 October
Atie, J.; Martelo, S.; Maciel, W.; Andrea, E.; Araujo, N.; Siqueira, L.; Carvalho, H.; Munhoz, C.F. 2003: Circumferential pulmonary vein ablation as a new anatomic approach for atrial fibrillation and predictive criteria for succesfull radiofrequency ablation. European Heart Journal 24(Abstract Suppl): 166
Eckardt, L.; Kirchhof, P.; Loh, P.; Wasmer, K.; Ribbing, M.; Moennig, G.; Breithardt, G. 2003: Circumferential pulmonary vein ablation guided by real-time, three-dimensional non-fluoroscopic localization of the Lasso catheter. European Heart Journal 24(Abstract Suppl): 597
Pappone, C.; Augello, G.; Vicedomini, G.; Gulletta, S.; Mazzone, P.; Gugliotta, F.; Santinelli, V.; Rosanio, S. 2003: Circumferential pulmonary vein ablation in patients with atrial fibrillation and associated systolic or diastolic heart failure. European Heart Journal 24(Abstract Suppl): 494
Pappone, Carlo; Rosanio, Salvatore; Tocchi, Monica; Gugliotta, Filippo; Vicedomini, Gabriele; Salvati, Adriano; Gulletta, Simone; Dicandia, Cosimo; Mazzone, Patrizio; Di Gioia, Claudio; Mognetti, Anna; Oreto, Giuseppe 2001: Circumferential radiofrequency ablation of pulmonary vein ostia for curing atrial fibrillation Long-term results from a large, single center experience. Journal of the American College of Cardiology 37(2 Suppl A): 107A
Coleman, J.A.; Phillips, J.; Wood, B.; Walther, M.; Linehan, W.M.rston 2003: Circumferential radiofrequency coagulation for partial nephrectomy and partial adrenalectomy. Journal of Urology 169(4 Suppl): 3
Peterson, F.C.; Bjork, T. 2003: Circumferential resecting reamer tool. Official Gazette of the United States Patent and Trademark Office Patents 1271(2)
Loudon, M.A. 2001: Circumferential stapled anoplasty in the management of prolapsing hemorrhoids Follow-up confirms durability. Gastroenterology 120(5 Suppl 1): A 284
Fontenot, M.G.; Feinberg, R.; Vining, J. 2003: Circumferential transillumination of anatomic junctions using light energy. Official Gazette of the United States Patent and Trademark Office Patents 1267(1)
Azegami, K.; Arruda, M.S.; Anders, R.; Wang, Z.; Burke, M.; Lin, A.; Swarup, V.; Wilber, D.J. 2002: Circumferential ultrasound ablation of pulmonary vein ostia Relationship between ablation time and lesion formation. Journal of the American College of Cardiology 39(5 Suppl A): 106A
Sparks, P.B.; Goseki, Y.; Roithinger, F.X.; Guerra, P.G.; Lesh, M.D. 1999: Circumferential ultrasound ablation of the coronary sinus and radiofrequency ablation of Bachmanns bundle modifies transeptal conduction. Circulation 100(18): 1; 373
Chu, A.O.K.; Chaly, N.; Chughtai, Z.; Matusiewicz, N.; Stochaj, U. 2000: Circumferin, a nuclear envelope protein that interacts with nucleoporins and is sensitive to stress. Biochemical Society Transactions 28(5): A443
Maschino, S.E.; Kollatschny, S.D. 2003: Circumneural electrode assembly. Official Gazette of the United States Patent and Trademark Office Patents 1272(5)
Murray, K.; Dutcher, G.; Iliff, J.; Elliott, S. 2002: Circumpolar Health Information Center The first year and hopes for the future. Arctic Science Conference Abstracts 53: 163
Doyle, J.F.; Parker, W.B.; Treadwell, M.; Wilkniss, P.E. 2000: Circumpolar infrastructure Strategies for international cooperation in the Arctic. Arctic Science Conference Abstracts 51: 54-55
Maeshima, S.; Maeshima, E.; Maeshima, S.; Itoh, N. 2002: Circumscribed forearm and leg hypesthesia from thalamic stroke. European Neurology 47(4): 244-245
Ide, F.; Mishima, K.; Saito, I. 2004: Circumscribed salivary duct carcinoma of the palate: a non-threatening variant. Histopathology 45(1): 89-91
Martin Corriente, M.C.; Manzano Sanz, C.; Hernandez Guerra, M.I.; Garcia Suarez, M.P.; Ravina Cabrera, M.D.; Mendez Medina, R.; Martin Herrera, A.I.; Martin Malagon, A. 1999: Circumscribed storiform collagenoma. Virchows Archiv 435(3): 310
Fredericq, S.; Anderson, R.J.; Lopez Bautista, J.M. 2003: Circumscription of some Phyllophoraceae from the Cape region, South Africa, based on molecular evidence. Chapman, Anthony R O, Anderson, Robert J, Vreeland, Valerie, Davison, Ian R Proceedings of the 17th International Seaweed Symposium: 263-273
Rathore, S.; Jackson, M.; Perry, R. 2002: Circumstances and clinical correlates of inhospital death after percutaneous transluminal coronary angioplasty Present era. Circulation 106(19): II587-II588
Bockholdt, B.; Maxeiner, H.; Hegenbarth, W. 2003: Circumstances and factors influencing the postmortem development of petechial bleedings in areas of hypostasis. Forensic Science International 136(Suppl 1): 271-272
Coleman, S.R. 2002: Circumstances and themes in the history of classical conditioning. Moore, John W A neuroscientist's guide to classical conditioning Edition 1 1-13
Somasekar, A.; Ong, J.; James, L.; Stephenson, B.M.; Vellacott, K.D.; Allison, M.C. 2004: Circumstances in which colonic investigations may fail to detect colorectal cancer. Gut 53(Suppl 3): A67
Baguet, J.P.; Hammer, L.; Tremel, F.; Chabre, O.; Chaffanjon, P.; Mallion, J.M. 2001: Circumstances of discovery of phaeochromocytoma Retrospective study of 29 patients. American Journal of Hypertension 14(4 Part 2): 256A
Eigenmann, P.A.; Zamora, S.A. 2002: Circumstances of food-induced reactions following the diagnosis of food allergy. Journal of Allergy and Clinical Immunology 109(1 Suppl): S335
Saluja, G.; Brenner, R.A.; Smith, G.S.; Schroeder, T. 2003: Circumstances of swimming pool drownings in youth aged 5-24, 1995-1998. Pediatric Research 53(4 Part 2): 199A
Miao, H.; Seyran, M.; Dagraca, J.V.; Skaria, M. 2003: Circumstantial evidence of natural spread of Citrus psorosis virus in Texas. Phytopathology 93(6 Suppl): S61-S62
Fish, D.N. 2001: Circumventing drug interactions. Piscitelli, Stephen C , Reprint Author, Rodvold, Keith A Drug interactions in infectious diseases: 311-331
Zhou, Z.C.; Zwelling, L.A.; Kawakami, Y.; Kleinerman, E.S. 1999: Circumventing drug resistance in human breast cancer cells by topoll alpha gene transfer using an adenoviral vector. Proceedings of the American Association for Cancer Research 40: 680
Clemens, P.R.; Jiang, Z.L.; Mccarthy, S.A.; Feingold, E.; Kochanek, S. 2001: Circumventing immunity in adenoviral vector gene delivery to skeletal muscle. Neurology 56(8 Suppl 3): A83
Saitta, S.; Zderic, S.; Anadiotis, G.; Colliton, R.; Celle, L.; Kline, R.; Spinner, N.; Zackai, E. 1999: Circumventing male infertility by ICSI should not preclude basic evaluation. American Journal of Human Genetics 65(4): A370
Voss, R.H.; Willemsen, R.; Kuball, J.; Kim, M.K.; Stanislawski, T.; Lotz, C.; Huber, C.; Bolhuis, R.; Theobald, M. 2000: Circumventing self-tolerance by transferring into human T-lymphocytes an A21 transgenic T cell receptor with high affinity for an universal hdm2 peptide epitope. Onkologie 23(Sonderheft 7): 54
Rogers, P.; Swannie, H.; Boxall, F.; Valenti, M.; Patterson, L.; Swindell, C.; Mcintire, G.; Bradley, M.; Johnston, S.; Kelland, L.R. 2002: Circumvention of acquired paclitaxel resistance in vivo by DHA-paclitaxel. Proceedings of the American Association for Cancer Research 43: 788
De Groot, Derk Jan; Timmer, Tineke; Le, Phuong; De Vries, Elisabeth; De Jong, Steven 2002: Circumvention of drug resistance by the Fas-mediated apoptosis pathway in a doxorubicin and cisplatin resistant small-cell lung cancer cell line. Proceedings of the American Association for Cancer Research 43: 709
Savaraj, N.; Wu, C.; Wang Paichitr, M.; Lampidis, T.; Robles, C.; Furst, A.J.; Feun, L. 2003: Circumvention of drug resistance in small cell lung cancer by mTOR inhibitor. Proceedings of the American Association for Cancer Research 44: 737
Hemmi, H.; Uchida, IIchiro; Zhong, X.; Takano, S.; Miyafuji, Y.; Tsujita, K.; Koi, M.; Shimatake, H. 2000: Circumvention of drug-resistance due to DNA mismatch repair-deficiency by DNA polymerase inhibitors. Proceedings of the American Association for Cancer Research 41: 179
Yu, B.; Mitchell, G.; Richter, A. 2003: Cirhin, the protein mutated in North American Indian childhood cirrhosis is a novel nucleolar protein. American Journal of Human Genetics 73(5): 565
Seyam, M.S.; Gunson, B.K.; Neuberger, J.M.; Hubscher, S.G. 2004: Cirrhosis after orthotopic liver transplantation in the absence of disease recurrence. Journal of Hepatology 40(Suppl 1): 55
Pianka, J.D.; Ricci, P. 2000: Cirrhosis associated with heterozygous alpha-1-antitrypsin deficiency preceded by a remote history of panniculitis. American Journal of Gastroenterology 95(7): 1848
Piscaglia, F.; Hermida, R.C.; Siringo, S.; Legnani, C.; Gaiani, S.; Donati, G.; Ramadori, G.; Gramantieri, L. 2000: Cirrhosis does not disrupt the output rhythm of the internal timekeeping system. Hepatology 32(4 Pt 2): 530A
Schafer, T.W.; Brann, O.S.; Schindler, W.R. 1999: Cirrhosis due to biliopancreatic diversion in an alcoholic. Gastroenterology 116(4 Part 2): A576
Adigun, A.Q.; Chalasani, N.; Groh, W.J.; Hall, S.D.; Gorski, J.C. 2002: Cirrhosis eliminates the gender differences in QTc interval. Clinical Pharmacology and Therapeutics 71(2): P9
Waters, B.; Ismail, M.K.; Fleckenstein, J.F.; Zua, M.S.; Smith, J.L.; Bockhold, K.M.; Riely, C.A. 1999: Cirrhosis is not a predictor of response with interferon and ribavirin retreatment of hepatitis C. Gastroenterology 116(4 Part 2): A1287
Hadoke, P.W. 2001: Cirrhosis of the liver and receptor-mediated function in vascular smooth muscle. Pharmacology and Therapeutics 89(3): 233-254
Desmet, V.J.; Roskams, T. 2004: Cirrhosis reversal: a duel between dogma and myth. Journal of Hepatology 40(5): 860-867
Oien, K.A.; Moffat, D.; Curry, G.W.; Dickson, J.; Habeshaw, T.; Mills, P.R.; MacSween, R.N. 1999: Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet 353(9146): 36-37
Therapondos, G.; Plevris, J.N.; Dollinger, M.M.; Flapan, A.D.; Hayes, P.C. 1999: Cirrhotic cardiomyopathy Echocardiographic findings, serum cardiac troponin I and B-type natriuretic peptide. Hepatology 30(4 Part 2): 437A
Torregrosa, M.; Aguade, S.; Dos, L.; Gonzalez, A.; Esteban, R.; Guardia, J.; Genesca, J. 2004: Cirrhotic cardiomyopathy is reversible after liver transplantation. Journal of Hepatology 40(Suppl 1): 68-69
Samson, C.M.; Hayden, M.A.; Bird, M.A.; Lange, P.A.; Brenner, D.A.; Behrns, K.E. 2001: Cirrhotic hepatocytes are resistant to TGFbeta1-induced apoptosis in primary murine hepatocytes. Hepatology 34(4 Pt 2): 270A
Graupera, M.; Garcia Pagan, J.C.; Gonzalez Abraldes, J.; Bosch, J.; Rodes, J. 2001: Cirrhotic livers exhibit a hyperesponse to methoxamine Role of nitric oxide and eicosanoids. Journal of Hepatology 34(Suppl 1): 66
Kato, N.; Otsuka, M.; Hoshida, Y.; Goto, T.; Moriyama, M.; Taniguchi, H.; Shiratori, Y.; Takayama, T.; Makuuchi, M.; Omata, M. 2001: Cirrhotic nodules exhibit identical mRNA expression profiles in spite of their different nodule sizes. Hepatology 34(4 Pt 2): 678A
Altuntaş, B.; Ozçakar, B.; Bideci, A.; Cinaz, P. 2002: Cirrhotic outcome in patients with craniopharyngioma. Journal of Pediatric Endocrinology and Metabolism: Jpem 15(7): 1057-1058
Caselman, W.H.; Hanke, P.; Serwe, M.; Rabe, C.; Pagenstecher, C.; Boehm, S.; Sauerbruch, T. 2001: Cirrhotic patients with or without hepatocellular carcinoma harbor AFP-specific CD4- and CD8-positive T-cells that can be activated in vitro by human AFP. Journal of Hepatology 34(Suppl 1): 207
Young, P.S. 2000: Cirripedia Thoracica collected during the Campagne de La Calypso from the Atlantic shelf of South America. Zoosystema 22(1): 85-100
Diez, P.A.; Fidalgo, P. 2003: Cirrospilus neotropicus sp n An indigenous biocontrol agent of the citrus leafminer, Phyllocnistis citrella in Argentina. Entomological News 114(2): 98-103
Mcclay, A.S.; Bourchier, R.S.; Butts, R.A.; Peschken, D.P. 2002: Cirsium arvense Scopoli, Canada thistle. Mason, P G , Reprint Author, Huber, J T 1981-2000: 318-330
Tofts, R. 1999: Cirsium eriophorum Scop. Journal of Ecology 87(3): 529-542
Kadota, Y.ichi 1999: Cirsium hupehense Pamp newly naturalized in Iwaki, Central Japan. Journal of Japanese Botany 74(4): 257-260
Metges, C.C.; Lehmann, L.; Boeuf, S.; Petzke, K.J.; Muller, A.; Franke, W.; Steinhart, H.; Nurnberg, G. 2003: Cis 12, trans 10-conjugated linoleic acid decreases fatty acid synthesis from glucose in primary white and brown adipocytes. FASEB Journal 17(4-5): Abstract 522
Parham, S.N.; Resende, C.G.; Cox, B.S.; Tuite, M.F. 2000: Cis and tns-acting factors affecting prion propagation in Saccharomyces cerevisiae. Biochemical Society Transactions 28(5): A348
Gibb, A.; Hamshere, M. 2002: Cis and trans disruption of DMPK alternative splicing in Myotonic Dystrophy Type-1. Journal of Medical Genetics 39(Suppl 1): S14
Ernst, D.; Aarts, M. 2004: Cis elements and transcription factors regulating gene promoters in response to environmental stress. Sandermann, H , Reprint Author Molecular ecotoxicology of plants: 151-176
Hilgenfeld, R.; Weiss, M.S.; Brandl, M.; Pal, D.; Riboldi Tunnicliffe, A.; Fischer, G.; Konig, B.; Vogel, A. 2002: Cis peptide bonds in proteins and cis/trans isomerases in intracellular parasites. Journal of Peptide Science 8(Suppl): S60
Zhang, S.; Stewart, G.C. 2000: Cis regulatory sequences responsible for expression and accessory gene regulator system control of the enterotoxin D gene promoter of Staphylococcus aureus. Abstracts of the General Meeting of the American Society for Microbiology 100: 99
Miranda, L.S.M.; Marinho, B.G.; Leitao, S.G.; Matheus, M.E.; Fernandes, P.D.; Vasconcellos, M.L.A.A. 2004: Cis- -formic acid A novel substance with antinociceptive properties. Bioorganic and Medicinal Chemistry Letters 14(6): 1573-1575, 22 March
Colangelo, D.; Ghiglia, A.Lisa.; Viano, I.; Cavigiolio, G.; Osella, D. 2003: Cis-[Pt(Cl)2(pyridine)(5-SO3H-isoquinoline)] complex, a selective inhibitor of telomerase enzyme. Biometals: An International Journal on the Role of Metal Ions in Biology Biochemistry and Medicine 16(4): 553-560
Trujillo, M.A.; Gomez, J.A.; Campos, J.; Espinosa, A.; Gallo, M.A. 2001: Cis- and trans-1- -1,4-dioxepan-5-ylpyrimidines A new nucleoside prototype with a seven-membered moiety. Tetrahedron 57(18): 3951-3961, 30 April
Pusateri, M.; Chitchumroonchokchai, C.; Schwartz, S.; Failla, M. 2003: Cis- and trans-isomer of lycopene in tomatoes and processed tomato foods digestive stability, micellarization and uptake by Caco-2 human intestinal cells. FASEB Journal 17(4-5): Abstract 425
Mcdonald, E.S.; Windebank, A.J. 1999: Cis- and transplatin binding to neuronal DNA. Society for Neuroscience Abstracts 25(1-2): 290
Ali, M.S.; Khokhar, A.R. 2003: Cis-1,4-Diaminocyclohexane-Pt and - adducts with DNA bases and nucleosides. Journal of Inorganic Biochemistry 96(4): 452-456, 1 September
Dwoskin, L.P.; Crooks, P.A.; Jones, M.D. 2002: Cis-2,6-disubstituted piperidines for the treatment of psychostimulant abuse and withdrawal, eating disorders, and central nervous system diseases and pathologies. Official Gazette of the United States Patent and Trademark Office Patents 1262(4)
Jacobsen, P.; Treppendahl, S.; Bury, P.S.; Kanstrup, A.; Christiansen, L.B. 2000: Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes. Official Gazette of the United States Patent and Trademark Office Patents 1232(4)
Yeo, T.; Balcar, V.J.; Chebib, M.; Johnston, G.A.R. 2003: Cis-4-aminocrotonic acid and its selectivity for neuronal GABA transporters. Journal of Neurochemistry 87(Suppl 1): 112
Chiu, C.K.; Meltz, M. 1999: Cis-6 -phenyl-5 -5,6,7,8-tetrahydronaphthalen-2-ol-D-tartrate. Official Gazette of the United States Patent and Trademark Office Patents 1226(1)
Nugent, A.P.; Gibney, M.J.; Roche, H.M. 2003: Cis-9, trans-11 conjugated linoleic acid and linoleic acid modulate the nuclear factor-kappaB family of transcription factors. Proceedings of the Nutrition Society 62(OCA-B): 26A, Autumn
Verdon, B.; Lees, G. 2000: Cis-9,10-octadecenoamide modulation of voltage-gated Na+ channels in NIE 115 mouse neuroblastoma cells. Journal of Physiology (Cambridge) 525P: 65P-66P
Babu, P.; Robinson, L.C. 2001: Cis-Acting sequences involved in Yck2p plasma membrane association. Molecular Biology of the Cell 12(Suppl): 345a-346a
Eagle, C.T.; Farrar, D.; Holder, G.N.; Hatley, M.L.; Humphrey, S.L.; Olson, E.V.; Quintos, M.; Sadighi, J.; Wideman, T. 2003: Cis-Enhanced cyclopropanation catalysts Reaction chemistry of three isomers of Rh2 COCH34. Tetrahedron Letters 44(12): 2593-2595
Lees, G.; Dougalis, A. 2002: Cis-Oleamide does not modulate serotonergic transmission in CA1 pyramidal cells of the rat hippocampal slice. Journal of Physiology (Cambridge) 544P: 70P
Asaoka, Y.; Kojima, D.; Mano, H.; Fukada, Y. 2000: Cis-acting DNA element responsible for tissue-specific expression of the two rhodopsin genes in zebrafish. Zoological Science 17: 101
Laughlin, J.L.; Oghlidos, S.; Singh, K.; Covey, L.R. 2003: Cis-acting element in the 3UTR of CD154 mRNA that aids in the stability of CD40 ligand in late-activated CD4+ T-cells. FASEB Journal 17(7): C226
Mehta, K.D. 1999: Cis-acting element in the human LDL receptor promoter and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1220(2): 1492
Sellers, R.S.; Tannehill Gregg, S.H.; Capen, C.C.; Rosol, T.J. 1999: Cis-acting elements in the 3-untranslated and coding regions of parathyroid hormone-related protein mRNA mediate transforming growth factor-beta induced stability. Journal of Bone and Mineral Research 14(Suppl 1): S546
Harris, L.R.; Miller, G.; Bridgewater, L.C. 2002: Cis-acting elements in the 5 region of the Col11a2 gene cooperate with two known enhancers to increase transcriptional activity. FASEB Journal 16(4): A4-A5
Yamaguchi, O.; Omata, T. 2001: Cis-acting elements involved in induction of the HCO3- transporter operon of the cyanobacterium Synechococcus sp PCC7942. Plant and Cell Physiology 42(Suppl): s173
Tanaka, M.; Wechsler, S.B.; Lee, I.W.; Yamasaki, N.; Izumo, S. 1999: Cis-acting elements regulate expression of the cardiac specific homeobox gene, Csx/Nkx2-5. Pediatric Research 45(4 Part 2): 32A
Andhare, R.; Cox, K.H.; Rai, R.; Cooper, T. 2002: Cis-acting elements responsible for GAT1 expression in Saccharomyces cerevisiae. Yeast 19(1): 88, 15 January
Grosovsky, A.J.; Allen, R.; Moore, S.R. 2003: Cis-acting mechanisms for genomic instability. Environmental and Molecular Mutagenesis 41(3): 219
Whitelaw, C.A.; Lyssenko, N.N.; Tucker, M.L. 1999: Cis-acting regulatory elements in the bean abscission cellulase gene promoter. Plant Biology (Rockville) : 187
Kawakami, K.; Salonga, D.; Omura, K.; Danenberg, K.D.; Park, J.M.; Uetake, H.; Brabender, J.; Watanabe, Y.; Danenberg, P.V. 2000: Cis-acting translational effects of the polymorphic repeat sequence of thymidylate synthase mRNA. Proceedings of the American Association for Cancer Research 41: 149
Eaton, K.A.; Gilbert, J.; Joyce, E.; Thevenot, T.; Baker, P.; Mefford, M.; Wright, A. 2000: Cis-complementation of Helicobacter pylori ureB restores colonizing potential and reflects promoter expression in vivo. Gut 47(Suppl 1): A26
Tanaka, M.; Ito, S.; Kiuchi, K. 1999: Cis-elements in 5-untranslated region of mouse GDNF. Society for Neuroscience Abstracts 25(1-2): 1273
Suzuki, K.; Hayashi, T. 2000: Cis-elements required for expression of human protein C inhibitor gene in HepG2 cells and its androgen-dependent expression in rat reproductive organs. Seminars in Thrombosis and Hemostasis 26(1): 75-83
Casey, C.P.; Dzwiniel, T.L. 2002: Cis-enediyne synthesis by cyclization of bis-alkynylcarbene manganese complexes. Abstracts of Papers American Chemical Society 224(1-2): INOR 371
Mueller, C.; Emmrich, S.; Sparmann, G.; Jaster, R.; Liebe, S.; Emmrich, J. 2003: Cis-hydroxyproline inhibits proliferation and induces apoptosis of pancreatic carcinoma cells. Pancreas 27(4): 397-398
Kong, N.; Liu, E.A.; Vu, B.T. 2003: Cis-imidazolines. Official Gazette of the United States Patent and Trademark Office Patents 1274(2)
Boileau, A.; Merchen, N.; Wasson, C.; Atkinson, C.; Erdman, J.Jr 1999: Cis-lycopene is more bioavailable than trans-lycopene in vitro and also in vivo in the lymph cannulated ferret. FASEB Journal 13(4 Part 1): A210
Karakozova, M.V.; Savitskaya, E.E.; Parshikov, A.F.; Georgiev, P.G. 2003: Cis-modifers of yellow repression induced by Su insulator in the absence of Mod protein. Doklady Akademii Nauk 389(5): 697-700
Zaheer, A.; Traynelis, V.C.; Sahu, S.K.; Ryken, T.C. 2004: Cis-parinaric acid effects forkhead transcription factor and Mn-SOD differentially in malignant and normal astrocytes. FASEB Journal 18(4-5): Abstract 163
Bayhan, G.; Aban, M.; Yayla, M.; Gül, T.; Yaldiz, M.; Erden, A.C. 1999: Cis-platinum combination chemotherapy during pregnancy for mucinous cystadenocarcinoma of the ovary. Case report. European Journal of Gynaecological Oncology 20(3): 231-232
Hallahan, D.L.; Coldren, C.; Flint, D.; Wang, H. 2003: Cis-prenyltransferases from plants. Official Gazette of the United States Patent and Trademark Office Patents 1276(2)
Dirksen, W.P.; Fisher, S.A. 1999: Cis-regulation of alternative splicing of the myosin-binding subunit of smooth muscle phosphatase pre-mRNA. FASEB Journal 13(4 Part 1): A437
Iwuchukwu, O.F.; Nagar, S. 2010: Cis-resveratrol glucuronidation kinetics in human and recombinant UGT1A sources. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 40(2): 102-108
Takemura, M.; Kimura, Y.; Takahashi, H.; Ishida, Y. 2002: Cis-substituted aminocyclopropane derivative. Official Gazette of the United States Patent and Trademark Office Patents 1263(2)
Takemura, M.; Kimura, Y.; Takahashi, H.; Ishida, Y. 2002: Cis-substituted aminocyclopropane derivatives. Official Gazette of the United States Patent and Trademark Office Patents 1258(3)
Takemura, M.; Takahashi, H.; Ohki, H.; Kimura, K.; Miyauchi, R.; Takeda, T. 2003: Cis-substituted fluoromethylpyrrolidine derivative. Official Gazette of the United States Patent and Trademark Office Patents 1277(1)
Smetana Just, U.; John, S.; Norval, M.; Walker, S.L. 2004: Cis-urocanic acid induces NFkappaB activation in primary human keratinocytes. Journal of Investigative Dermatology 123(2)
Langen, K.J.; Muehlensiepen, H.; Schmieder, S.; Hamacher, K.; Borner, A.R.; Coenen, H.H. 2002: Cis/trans-4-18F-fluoro-L-proline Transport mechanisms in F98 glioma cells. Journal of Nuclear Medicine 43(5 Suppl): 363P
Jacobsen, P.; Treppendahl, S.; Bury, P.S.; Kanstrup, A.; Christiansen, L.B. 2001: Cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes. Official Gazette of the United States Patent and Trademark Office Patents 1252(2)
Kearns, G.L.; Lowry, J.; Khan, I.; Kashuba, A.; Bertino, J.; Nafziger, A.; Abdel Rahman, S.; Leeder, J. 2002: Cisapride A potential model substrate to assess CYP3A4 activity. Clinical Pharmacology and Therapeutics 71(2): P104
Vandenplas, Y. 2000: Cisapride guidelines. Journal of Pediatric Gastroenterology and Nutrition 31(2): 212
Suchitra, A.D.; Dkhar, S.A.; Shewade, D.G.; Shashindran, C.H. 2002: Cisapride and metoclopramide on GI inertia in morphine treated mice. Indian Journal of Pharmacology 34(2): 149
Poplawski, C.; Loftiss, M.; Sarosiek, I.; Brown, R.; Mccallum, R.W.; Sarosiek, J. 1999: Cisapride augments salivary secretion, mediated by esophago-salivary reflex evoked by intraesophageal exposure to acid, pepsin and bile acids. Gastroenterology 116(4 Part 2): A301
Poplawski, C.; Skoczylas, T.; Loftiss, M.; Sarosiek, I.; Brown, R.; Mccallum, R.W.; Sarosiek, J. 2000: Cisapride augments the esophageal pre-epithelial barrier during the mucosal challenge with acid, pepsin and bile acids, mimicking the natural duodenogastroesophageal reflux scenario. Gastroenterology 118(4 Suppl 2 Pt 1): A18
Gotschall, R.R.; Marcucci, K.; Leeder, J.S.; Kearns, G.L. 1999: Cisapride biotransformation Not all CYP3As are created equal. Clinical Pharmacology and Therapeutics 65(2): 127
Kikkert, M.A.; Mirmiran, M.; Conrad, C.K.; Baldwin, R.B.; Ariagno, R.L. 2000: Cisapride decreases gastroesophageal reflux in symptomatic preterm infants. Pediatric Research 47(4 Part 2): 407A
Kearns, G.L.; Robinson, P.; Adcock, K.; Wilson Costello, D.; Knight, G.; Zhou, H.H.; Ward, R.; Van Den Anker, J.; Ppru Network 2001: Cisapride disposition in neonates and infants. Clinical Pharmacology and Therapeutics 69(2): P31
Jans, E.M.rie Jozef; Gilis, P.M.rie Victor 2000: Cisapride extended release. Official Gazette of the United States Patent and Trademark Office Patents 1240(4)
Dhiman, R.K.; Arke, L.; Bhansali, A.K.; Gupta, S.; Chawla, Y.K. 2000: Cisapride improves gallbladder emptying in patients with diabetes. Diabetes Research and Clinical Practice 50(Suppl 1): S333
Dhiman, R.K.; Arke, L.; Bhansali, A.; Gupta, S.; Chawla, Y. 1999: Cisapride improves gallbladder emptying in patients with diabetes mellitus. Hepatology 30(4 Part 2): 424A
Jackson, W.; Vasani, J.; Tsai, H.H.; Wedgwood, K.R. 2000: Cisapride improves non-mechanical symptomatic dysphagia A manometric assessment. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A627
Vandenplas, Y. 1999: Cisapride in constipation. Journal of Pediatric Gastroenterology and Nutrition 29(4): 487
Clancy, M.J.seph Anthony; Cumming, K.I.in 2000: Cisapride mini-tablet formulations. Official Gazette of the United States Patent and Trademark Office Patents 1237(5)
Feenstra, A.; Benatar, A.; Decraene, T.; Vandenplas, Y. 1999: Cisapride plasma levels and effects on QTc interval and heart rate infants. JPGN 28(5): 553
Zamora, S.A.; Belli, D.; Ferrazzini, G.; Friedli, B. 1999: Cisapride prolongs ventricular repolarization but does not generate ventricular late potentials in infants. JPGN 28(5): 574
Van 't Klooster, Gerben Albert Eleutherius 2000: Cisapride sustained release. Official Gazette of the United States Patent and Trademark Office Patents 1239(1)
Keefe, D.L.; Chong, M.; Leone, D.; Timoney, J. 2000: Cisapride usage in tertiary referral center. Journal of Clinical Pharmacology 40(9): 1063
Utmemphis/Adc Study Group 1999: Cisapride use decreases hospital days, and admissions for aspiration pneumonia in a tube-fed developmentally disabled population. Gastroenterology 116(4 Part 2): A583
Orenstein, S.R.; Shalaby, T.M.; Frankel, E.A.; Kelsey, S.F. 2000: Cisapride, cimetidine, both, or neither for infantile esophagitis Symptomatic and histologic results of 2-months randomized, double-blind, placebo-controlled therapy in 100 babies. Gastroenterology 118(4 Suppl 2 Pt 1): A20
Miller, D.; Wherrett, C.; Watson, J.; Legault, S.; Hull, K. 1999: Cisatracurium vs rocuronium Cumulation potential associated with prolonged, infusions during general anesthesia. Canadian Journal of Anaesthesia 46(5 Part 2): A37
Pedani, F.; Airoldi, M.; Marchionatti, S.; Bumma, C. 2003: Cisplatin + irinotecan in recurrent/metastatic salivary gland malignancies. EJC Suppls 1(5): S44
Airoldi, M.; Marchionatti, S.; Pedani, F.; Bumma, C. 2003: Cisplatin + vinorelbine in recurrent salivary gland malignancies Final report on 42 cases. EJC Suppls 1(5): S38
Daponte, A.; Rivellini, F.; Gravina, A.; Ascierto, P.A.; D'aniello, R.; Mozzillo, N.; Caraco, C.; Comella, P.; Castello, G.; Comella, G. 1999: Cisplatin , dacarbazine , interferon and amifostine in advanced melanoma A phase I study. European Journal of Cancer 35(Suppl 4): S373
Seifart, U.; Hans, K.; Merte, H.; Neubauer, A.; Wolf, M. 2000: Cisplatin , ifosfomide and concurrent irradiation as neoadjuvant therapy locally advanced non-small cell lung cancer. Onkologie 23(Sonderheft 7): 15
Panza, N.; Frasci, G.; Comella, P.; Nicolella, G.; Natale, M.; Muci, D.; Palmeri, S.; Ruffolo, P.; Gravina, A.; Comella, G. 1999: Cisplatin - Paclitaxel - Topotecan weekly administration in chemo-naive or pretreated extensive disease small cell lung cancer A SICOG phase II study. European Journal of Cancer 35(Suppl 4): S252
Frasci, G.; Comella, P.; D'aiuto, G.; Apicella, A.; Thomas, R.; Capasso, I.; Carteni, G.; De Lucia, L.; Maiorino, L.; Comella, G. 1999: Cisplatin - epirubicin - paclitaxel weekly administration with G-CSF support in advanced breast cancer A phase II study. European Journal of Cancer 35(Suppl 4): S318
Frasci, G.; Comella, P.; Panza, N.; Nicolella, G.; Bilancia, D.; Cioffi, R.; Micillo, E.; Lorusso, V.; De Cataldis, G.; Comella, G. 1999: Cisplatin - gemcitabine - paclitaxel in the treatment of advanced non-small-cell lung cancer A southern Italy cooperative oncology group phase II study. European Journal of Cancer 35(Suppl 4): S256
Kishore, Bellamkonda K.; Krane, Carissa M.; Di Iulio, Darren; Menon, Anil G.; Cacini, William 1999: Cisplatin -induced polyuria in rats is associated with down regulation of medullary collecting duct water channels AQP2 and AQP3. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 648A
Thuss Patience, P.C.; Kretzschmar, A.; Tilgner, J.; Charles, A.; Doerken, B.; Reichardt, P. 1999: Cisplatin /5-FU as 2nd-line chemotherapy after CPT-11 failure for patients with metastatic gastric adenocarcinoma. European Journal of Cancer 35(Suppl 4): S149-S150
Andrews, P.A. 2000: Cisplatin accumulation. Kelland, Lloyd R Author, Farrell, Nicholas P Author Cancer Drug Discovery and Development; Platinum-based drugs in cancer therapy 89-113
Park, M.S.; Devarajan, P. 2001: Cisplatin activates mitochondrial apoptotic pathways in LLC-PK1 cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 599A
Massade, L.; Massaad, C.; Legendre, F.; Chottard, J.C.; Barouki, R.; Beaune, P. 1999: Cisplatin adducts decrease binding of the human estrogen receptor to estrogen response element. Proceedings of the American Association for Cancer Research 40: 158
Shaw, J. 1999: Cisplatin analogs for cancer treatment. Official Gazette of the United States Patent and Trademark Office Patents 1224(2)
Kolb, R.J.; Barfuss, D.W. 2003: Cisplatin and N-acetyl-L-cysteine-cDDP transport and toxicity in S2 and S3 proximal tubular segments. FASEB Journal 17(4-5): Abstract
Kupets, R.S.; Rosen, B.P.; Murphy, J. 1999: Cisplatin and Taxol Are survival results from GOG 111 high when compared to survival results from all patients attending individual centers?. Gynecologic Oncology 72(3): 508
Liu, H.C.; Liang, D.C.; Chen, S.W.; Chung, P.Y.; Sheu, J.C.; Wang, N.N. 2001: Cisplatin and epirubicin in hepatoblastoma 9-Year experience at a single institution. Pediatric Research 49(4 Part 2): 219A
Sundstrom, S.; Bremnes, R.M.; Kaasa, S.; Aamdal, S. 2001: Cisplatin and etoposide is superior to cyclophosphamide, epirubicin, and vincristin in small cell lung cancer Results from a randomized phase III trial with 5 years follow-up. European Journal of Cancer 37(Suppl 6): S153
Sato, Y.; Hamabe, Y.; Ikuta, H.; Nakamura, Y.; Yamamoto, M.; Kuroda, Y. 1999: Cisplatin and fluorouracil combined chemotherapy for unresectable esophageal cancer. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 164
Shaw, J. 2001: Cisplatin and folic acid administered to treat breast cancer. Official Gazette of the United States Patent and Trademark Office Patents 1251(1)
Zinner, R.; Glisson, B.; Pisters, K.; Khuri, F.; Oh, Y.; Ro, J.; Ordonez, N.; El Naggar, A.; Tran, H.; Herbst, R. 2001: Cisplatin and gemcitabine combined with Herceptin in patients with HER2 overexpressing, untreated, advanced, non-small-cell lung cancer A phase II trial. European Journal of Cancer 37(Suppl 6): S154
Lajer, H.; Daugaard, G. 1999: Cisplatin and hypomagnesemia. Cancer Treatment Reviews 25(1): 47-58
Kunitoh, H.; Saijo, N.; Nagao, K.; Ohashi, Y.; Niitani, H. 1999: Cisplatin and irinotecan versus CDDP and vindesine in advanced non-small cell lung cancer A multicenter phase III study. European Journal of Cancer 35(Suppl 4): S249-S250
Chandrasekhar, K.; Malathi, R. 2003: Cisplatin and self splicing activity of group-I intron ribozyme. Journal of Biomolecular Structure and Dynamics 20(6): 846
Bender, D.P.; Makhija, S.; Taylor, D.D.; Gercel Taylor, C. 2000: Cisplatin and taxol-induced caspase-3 activity in ovarian cancer cell monolayer and spheroids. Proceedings of the American Association for Cancer Research 41: 275
Mcdonald, E.S.; Windebank, A.J. 2002: Cisplatin binds to DNA in dorsal root ganglia neurons with high affinity A potential mechanism for dose-limiting neurotoxicity. Neurology 58(7 Suppl 3): A378-A379
Donovan, J.; Weinrib, L.; Li, J.H.; F.Liu 1999: Cisplatin chemotherapy enhances tumor suppression effects of adenoviral-p53 gene therapy in nasopharyngeal carcinoma. Proceedings of the American Association for Cancer Research 40: 95
Jain, N.; Brar, G.S.; Bhatia, A.K.; Devgan, R.; Dhaliwal, U.S. 2002: Cisplatin concomittant with radiotherapy in locally advanced cancers. International Journal of Cancer Suppl (13): 458
Li, Y.J.; Banerjee, S.; Franks, D.J.; Wilkins, R.C.; Stewart, D.J.; Ng, C.E.; Goel, R. 2002: Cisplatin cytotoxicity in MDCK cells. Proceedings of the American Association for Cancer Research 43: 62
Kim, S.W.; Yoo, K.S.; Kang, D.G.; Yeum, C.H.; Nah, M.Y.; Kim, N.H.; Lee, J.U.; Choi, K.C. 2000: Cisplatin decreases the abundance of aquaporin water channels in the kidney in rats. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 17A
Choi, K.C.; Nah, M.Y.; Kim, S.W.; Kang, D.G.; Lee, J. 2000: Cisplatin decreases the abundance of aquaporin-2 water channels in the kidney of rats. Nephrology Dialysis Transplantation 15(9): A10
Nakamura, T.; Hori, S.; Hidaka, T.; Saito, S.; Westphal, H. 2003: Cisplatin enhances the p53-independent apoptosis in the lens epithelial cell tumor induced by CPT-11. Proceedings of the American Association for Cancer Research 44: 1015
Ramesh, G.; Reeves, W.B.ian 2003: Cisplatin increases TNF-a mRNA stability and translation in mouse kidney proximal tubule cells. Journal of the American Society of Nephrology 14(Abstracts Issue): 274A
Yazlovitskaya, E.M.; Cui, W.; Pelling, J.C.; Persons, D.L. 1999: Cisplatin induced activation of MAP kinases in ovarian carcinoma cells Inhibition of ERK activity enhances sensitivity to cisplatin. Proceedings of the American Association for Cancer Research 40: 483
De Jong, Steven; Timmer, Tineke; Dam, Wendy A.; Kreileman, Nathaly; Mulder, Nanno H.; Ge De Vries, Elisabeth 2000: Cisplatin induced apoptosis correlates with activation of the Fas/Fas ligand signaling pathway in testicular germ cell tumor cell lines. Proceedings of the American Association for Cancer Research 41: 100
Murrie, V.L.; Gill, J.S.; Podratz, J.L.; Windebank, A.J. 1999: Cisplatin induced apoptosis in sensory neurons is associated with transition into G1 but not S phase of the cell cycle. Society for Neuroscience Abstracts 25(1-2): 290
Podratz, J.L.; Knight, A.M.; Fischer, S.J.; Gross, L.; Windebank, A.J. 2003: Cisplatin induced apoptosis requires cyclin D1 activation but does not involve transition to S phase in DRG neurons. Neurology 60(5 Suppl 1): A385
Jeyapalan, J.C.; Tilby, M.J.; Von Zglinicki, T. 2003: Cisplatin induced neuroblastoma cell death and the invovlement of telomeres. British Journal of Cancer 88(Suppl 1): S39
Yan, X.J.; Rosales, N.; Aghajanian, C.; Spriggs, D. 1999: Cisplatin induces NF-kappaB binding activity through IKB kinase dependent pathway. Proceedings of the American Association for Cancer Research 40: 195
Durak, I.; Karaayvaz, M.; Cimen, M.Y.B.; Avcy, A.; Ozbek, H.; Buyukkocak, S.; Ozturk, H.S. 2000: Cisplatin induces acute renal failure by impairing antioxidant system in guinea pigs. Biochemical Society Transactions 28(5): A200
Azuma, M.; Tamatani, T.; Ashida, Y.; Takashima, R.; Harada, K.; Sato, M. 2003: Cisplatin induces apoptosis in oral squamous carcinoma cells by the mitochondria-mediated but not the NF-kappaB-suppressed pathway. Oral Oncology 39(3): 282-289
Salganik, R.; Sivashinskiy, M.; Albright, C.; Vaisman, A.; Zeisel, S. 1999: Cisplatin mode of action in relation to heterogeneity of breast cancer cells Role of DNA platination, reactive oxygen species and antioxidants. FASEB Journal 13(5 Part 2): A916
Tsai, W.S.; Chen, G.A.; Schrump, D.S.; Nguyen, D.M. 2003: Cisplatin potentiates Apo2L/TRAIL -mediated induction of apoptosis in esophageal cancer cells by recruitment of the mitochondria-dependent death signaling pathways. Proceedings of the American Association for Cancer Research 44: 426
Takagi, Y.; Miyauchi, A.; Kurosu, I.; Takahashi, K.; Fujii, Y.; Fujita, T. 1999: Cisplatin regulates bone turnover in patients with lung cancer. Journal of Bone and Mineral Research 14(Suppl 1): S221
Chau, Q.; Stewart, D.J. 1999: Cisplatin resistance and intracellualr pH in human lung and ovarian cancer cells. Proceedings of the American Association for Cancer Research 40: 672
Dempke, W.; Voigt, W.; Schmoll, H.J.; Hill, B.T. 1999: Cisplatin resistance in human tumor cell lines is associated with DNA polymerase beta expression but not with thymidilate synthase expression. European Journal of Cancer 35(Suppl 4): S193
Stewart, D.J.; Dahrouge, S. 1999: Cisplatin resistance in lung cancer and dose-response curve shape. Proceedings of the American Association for Cancer Research 40: 186
Brown, R. 2000: Cisplatin resistance in ovarian cancer Mismatch repair and engagement of apoptosis. Kelland, Lloyd R , Farrell, Nicholas P Cancer Drug Discovery and Development; Platinum-based drugs in cancer therapy 115-128
Schenk, P.W.; Boersma, A.W.M.; Brok, M.; Brandsma, J.A.; Den Dulk, H.; Brouwer, J.; Burger, H.; Stoter, G.; Nooter, K. 2001: Cisplatin resistance in vitro Possible sensitivity genes in translational research from yeast to man. Proceedings of the American Association for Cancer Research 42: 931
Safaei, R.; Katano, K.; Samimi, G.; Naerdemann, W.; Howell, S.B. 2002: Cisplatin resistance is mediated by copper homeostatis mechanisms. Proceedings of the American Association for Cancer Research 43: 423
Komuro, Y.uki; Udagawa, Yasuhiro; Nobuyuki, Susumu; Aoki, Daisuke; Kubota, Tetsuro; Nozawa, Shiro 2002: Cisplatin resistance overcome by down-regulating the influx and efflux system with paclitaxel and SN-38 in ovarian cancer cell lines. Proceedings of the American Association for Cancer Research 43: 952
Suganuma, K.; Kubota, T.; Otani, Y.; Watanabe, M.; Kitajima, M. 2001: Cisplatin resistance-related genes of gastric cancer detected by cDNA microarray. Proceedings of the American Association for Cancer Research 42: 266
Yokoyama, S. 1999: Cisplatin resistant cell line. Official Gazette of the United States Patent and Trademark Office Patents 1218(2): 1274
Piche, A.; Belanger, S.; Garon, G.; Bergeron, C.; Rancourt, C. 2001: Cisplatin sensitivity of human mesothelial cells. Proceedings of the American Association for Cancer Research 42: 638
Dale, O.; Mortensen, B.; Thommesen, L.; Hagen, B. 2000: Cisplatin toxicity in the rat may be influenced by anaesthetic agents. Acta Anaesthesiologica Scandinavica 44(6): 770
Bhat, S.; Nie, Z.; Ramkumar, V. 1999: Cisplatin up-regulates A1 adenosine receptor in rat testes. FASEB Journal 13(4 Part 1): A461
Aravantinos, G.; Dimopoulos, M.A.; Athanasiou, H.; Fountzilas, G.; Samantas, E.; Kiamouris, C.; Skarlos, D.V. 1999: Cisplatin versus carboplatin based chemotherapy as induction chemotherapy of bladder cancer. European Journal of Cancer 35(Suppl 4): S346
Peters, W.A.IIi; Liu, P.Y.; Barrett, R.; Gordon, W., J.; Stock, R.; Berek, J.F.; Disaia, P.J.; Souhami, L.; Grigsby, P.; Alberts, D.S. 1999: Cisplatin, 5-fluorouracil, plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy Report of a Phase III Intergroup Study. Gynecologic Oncology 72(3): 443
Schöndorf, T.; Neumann, R.; Benz, C.; Becker, M.; Riffelmann, M.; Göhring, U.-J.; Sartorius, J.; von König, C.-H.W.; Breidenbach, M.; Valter, M.M.; Hoopmann, M.; Di Nicolantonio, F.; Kurbacher, C.M. 2003: Cisplatin, doxorubicin and paclitaxel induce mdr1 gene transcription in ovarian cancer cell lines. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 161: 111-116
Klein, E.W.; Lamm, D.L.; Hogan, T.; Nseyo, U.O.; Kandzari, S.J. 2000: Cisplatin, gemcitabine and paclitaxel chemotherapy of advanced bladder cancer. Journal of Urology 163(4 Suppl): 236
Helmbach, H.; Kern, M.A.; Rossmann, E.; Renz, K.; Gschwendt, B.; Schadendorf, D. 2001: Cisplatin- and etoposide resistance in human melanoma is associated with different modulations of the apoptotic pathway. Archives of Dermatological Research 293(1-2): 67
Segura, A.; Yuste, A.; Pastor, M.; Lopez Tendero, P.; Perez Fidalgo, J.A.; Girones, R.; Montalar, J. 2002: Cisplatin-5-Fluorouracilo versus cisplatin-vinorelbine in the treatment of locally advanced head and neck epidermoid carcinomas. Oncologia 25(10): 56-61
Hoebers, F.J.P.; Pluim, D.; Bartelink, H.; Balm, A.J.M.; Begg, A.C.; Rasch, C.R.N.; Schellens, J.H.M.; Verheij, M. 2003: Cisplatin-DNA adduct measurements in head and neck cancer patients treated by chemoradiotherapy. EJC Suppls 1(5): S37-S38
Barni, S.; Visini, M.; Piazza, E.; Ionta, M.T.; Arnoldi, E.; Ardizzoia, A.; Giardina, G.; Fava, S.; Viola, P.; Cazzaniga, M.; Ucci, G.; Massidda, B.; Nosenzo, A.; Villa, S. 2001: Cisplatin-Epirubicin-Vinorelbine A new neoadjuvant chemotherapy for stage T2-3/N0-2 breast cancer patients. Breast Cancer Research and Treatment 69(3): 300
Kelland, L.R. 1999: Cisplatin-based anticancer agents. Farrell, N P Uses of inorganic chemistry in medicine 109-123
Ionta, M.T.; Murru, R.; Scanu, A.; Atzori, F.; Massidda, B. 2001: Cisplatin-based chemotherapy A disproportionate myelotoxic effect. Breast 10(Suppl 1): S30
Hall, K.; Son, K. 2000: Cisplatin-based inducible nitric oxide synthase gene therapy of drug-resistant human breast carcinoma. Proceedings of the American Association for Cancer Research 41: 466
Son, K.; Wang, X.; Wang, Q. 1999: Cisplatin-based inducible nitric oxide synthase gene therapy of drug-resistant human ovarian carcinoma. Proceedings of the American Association for Cancer Research 40: 597
Son, K. 1999: Cisplatin-based tumor necrosis factor-related apoptosis-inducing ligand gene therapy of human breast carcinoma resistant to drugs or hormone. Breast Cancer Research and Treatment 57(1): 54
Kawai, H.; Kiura, K.; Ueoka, H.; Yoshino, T.; Tabata, M.; Chikamori, K.; Horita, N.; Nagata, T.; Takada, I.; Harada, M. 1999: Cisplatin-containing chemotherapy upregulates multidrug-resistance associated protein 3 and metallothionein. Proceedings of the American Association for Cancer Research 40: 668-669
Turchi, J.J.; Henkels, K.M.; Zhou, Y. 2000: Cisplatin-damaged DNA inhibition of DNA-PK, effects on cellular sensitivity to ionizing radiation. International Journal of Molecular Medicine 6(Suppl 1): S67
Dieras, V.; Ferrero, J.M.; Kheder, R.; Weber, B.; Winckel, P.; Lortho Lary, A.; Mayer, F.; Paraiso, D.J.; Pujade Lauraine, E. 1999: Cisplatin-docetaxel in first line treatment of advanced ovarian cancer. European Journal of Cancer 35(Suppl 4): S243
Panza, N.; Frasci, G.; Nicolella, G.P.; Comella, P.; Maiorino, L.; Muci, D.; Farris, A.; Lamberti, A.; Barbato, E.; Comella, G. 2001: Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in extensive SCLC A SICOG phase II study. European Journal of Cancer 37(Suppl 6): S62
Comella, P.; Panza, N.; Nicolella, G.P.; Manzione, L.; Lorusso, V.; Cioffi, R.; Decataldis, G.; Maiorino, L.; Bilancia, D.; Comella, G. 1999: Cisplatin-gemcitabine-vinorelbine vs cisplatin-vinorelbine vs cisplatin-gemcitabine in advanced non-small cell lung cancer Interim analysis of a SICOG phase III trial. European Journal of Cancer 35(Suppl 4): S247
Bates, L.; Portilla, D. 1999: Cisplatin-induced PPARalpha inhibition precedes apoptosis/necrosis in LLCPK1 cells. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 644A
Deschesnes, R.G.; Huot, J.; Landry, J. 2001: Cisplatin-induced apoptosis c-myc-dependent associated with caspase-independent activation of p38 MAP kinase. Proceedings of the American Association for Cancer Research 42: 130
Fischer, S.J.; Gross, L.; Windebank, A.J. 1999: Cisplatin-induced apoptosis in a rat model. Society for Neuroscience Abstracts 25(1-2): 1295
Lau, A.; Li, C.J.; Santos, A.; Warso, M.; Das Gupta, T.; Yu, R.; Kong, T. 1999: Cisplatin-induced apoptosis in melanoma cells. Clinical Pharmacology and Therapeutics 65(2): 196
Esposito, C.; Semeraro, L.; Bellotti, N.; Cornacchia, F.; Fasoli, G.; Mazzullo, T.; Dal Canton, A. 1999: Cisplatin-induced apoptosis is not mediated by nitric oxide in human epithelial tubular cells. Nephrology Dialysis Transplantation 14(9): A5
Razzaque, M.S.; Nazneen, A.; Liu, D.; Koji, T.; Taguchi, T. 1999: Cisplatin-induced apoptosis of renal proximal tubular epithelial cells is associated with activation of the Fas/Fas ligand system both in vitro and in vivo. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 650A
Qin, L.F.; Ng, I.O.L. 2000: Cisplatin-induced expression of cell cycle regulators and Fas in hepatoma cell line. Proceedings of the American Association for Cancer Research 41: 100
Basnakian, A.G.; Yin, X.; Apostolov, E.O.; Shah, S.V. 2003: Cisplatin-induced nephrotoxicity is mediated by DNase I. Journal of the American Society of Nephrology 14(Abstracts Issue): 567A
Makhalova, J.; Katsarava, Z.; Liedert, B.; Koeppen, S.; Thomale, J.; Limmroth, V. 2002: Cisplatin-induced neurotoxicity Formation and repair of specific cisplatin-DNA lesions in different cell types of nervous tissue in wild type and XPC-knockout mice. Neurology 58(7 Suppl 3): A19
Kirchmair, R.; Rittig, K.; Murayama, T.; Walter, D.H.; Emanueli, C.; Bahlmann, F.H.; Silver, M.; Schratzberger, P.; Isner, J.M. 2001: Cisplatin-induced peripheral neuropathy is the result of vascular injury to the vasa nervorum and may benefit from therapeutic angiogenesis. Circulation 104(17): 2; 317
Movahhed, A.; Bahrami, S.; Sanahmadi, Y.; Bahrami, Z.S.; Shirazi, F.H. 2003: Cisplatin-induced platinum-DNA cross-links in human ovarian adenocarcinoma cells. Toxicology Letters (Shannon) 144(Suppl 1): s126-s127
Cummings, B.S.; Aleo, M.; Schnellmann, R.G. 2001: Cisplatin-induced renal cell apoptosis is mediated by p53 and caspase 3 independently of caspase 8 or 9. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 799A
Kishore, B.K.; Cacini, W.; Diiulio, D.; Rouillard, P.; Doran, J.J.; Sands, J.M. 2000: Cisplatin-induced reversal of urea concentration gradient in rat kidney is not associated with significant changes in urea transporter abundance. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 603A
Kim, H.K.; Sasaki, H.; Aoyagi, K.; Ashida, A.; Yoshida, T.; Park, J.G.; Terada, M. 2002: Cisplatin-inducible genes identified by the DNA oligonucleotide microarray analysis in esophageal cancer cell lines. Proceedings of the American Association for Cancer Research 43: 1086
Yang, J.; Chen, Z. 2003: Cisplatin-mediated DNA damage increased apoptosis by xeroderma pigmentosum group C protein in bladder transitional cell carcinoma. Journal of Urology 169(4 Suppl): 191
Mcdonald, E.S.; Windebank, A.J. 2001: Cisplatin-mediated apoptosis of DRG neurons is linked to the redistribution of cytosolic Bax and cytochrome c release but not to fas receptor signaling. Neurology 56(8 Suppl 3): A395
Malhotra, H.; Plosker, G.L. 2001: Cisplatin/epinephrine injectable gel. Drugs and Aging 18(10): 787-793; Discussion: 794-795
Hauschild, A.; Oratz, R.; Sebastian, G.; Broecker, E.B.; Riess, H.; Orenberg, E.K. 2001: Cisplatin/epinephrine injectable gel for the intralesional treatment of melanoma metastases Results of a multi-institutional trial. European Journal of Cancer 37(Suppl 6): S238
Camps, C.; Alberola, V.; Provencio, M.; Isla, D.; Rosell, R.; Vadell, C.; Bover, I.; Ruiz Casado, A.; Azagra, P.; Jimenez, U. 2001: Cisplatin/gemcitabine vs cisplatin/gemcitabine/vinorelbine vs sequential doublets of gemcitabine/vinorelbine followed by ifosfamide/vinorelbine in advanced non-small cell lung cancer Final results of a Spanish lung cancer group phase III trial. European Journal of Cancer 37(Suppl 6): S28
Costa, S.D.; Du Bois, A.; Lueck, H.J.; Meier, W.; Moebus, V.; Bauknecht, T.; Richter, B.; Schroeder, W.; Warms, S.; Olbricht, S. 2001: Cisplatin/paclitaxel vs carboplatin/paclitaxel in 798 patients with ovarian cancer FIGO IIB-IV Randomized phase III study the AGO Study Group. European Journal of Cancer 37(Suppl 6): S325
Alexandre Moreira, M.S.; Freire, D.L.ma, C.G.; Arruda Hinds, L.B.; Trindade, M.N.; Correia, A.B.A.; Chagas, K.K.F.; Decote Ricardo, D.; Piuvezam, M.R.; Pecanha, L.M.T. 2000: Cissampelos sympodialis inhibits the microbicide activity of Trypanosoma cruzi-infected macrophages through the inhibition of nitric oxide production. Memorias do Instituto Oswaldo Cruz 95(Suppl 2): 223
Arrington, J.M.; Kubitzki, K. 2003: Cistaceae. Kubitzki, Klaus , Reprint Author, Bayer, Clemens Flowering plants, Dicotyledons: Malvales, Capparales and non-betalain Caryophyllales: 62-70
Fernandez Calienes Valdes, A.; Mendiola Martinez, J.; Hernandez Alvarez, H.; De La Vega, Rafael 2003: Cistein proteinases in the Boophilus microplus ovary. Acarologia 43(3): 229-238
Kodama, N.; Matsumoto, M.; Sasaki, T.; Konno, Y.; Sato, T. 2001: Cisternal irrigation therapy with urokinase and ascorbic acid for prevention of vasospasm. Acta Neurochirurgica. Supplement 77: 171-174
Nakagomi, T.; Takagi, K.; Narita, K.; Nagashima, H.; Tamura, A. 2001: Cisternal washing therapy for the prevention of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Acta Neurochirurgica. Supplement 77: 161-165
García-González, J.J.; Crespo, V.; Barber, D.; Miranda, A.; Vega-Chicote, J.M.; Carmona, M.J.; Negro, M.A.; Lombardero, M.; Ameal, A.; Barceló-Muñoz, J.M. 2001: Cistus ladanifer contact dermatitis. Contact Dermatitis 45(4): 238
D.J.ng, T.R.; Pattij, T.; Veening, J.G.; Waldinger, M.D.; Cools, L.R.; Olivier, B. 2003: Citalopram alone does not, but combined with a silent 5-HT1A receptor antagonist does, inhibit male sexual behaviour. Hormones and Behavior 44(1): 45
Najjar, F.; Price, L.H. 2004: Citalopram and dystonia. Journal of the American Academy of Child and Adolescent Psychiatry 43(1): 8-9
Hall, J.; Naranjo, C.; Sproule, B.; Herrmann, N. 2002: Citalopram and fluoxetine differentially alter alprazolam concentrations. Clinical Pharmacology and Therapeutics 71(2): P52
Pravin, D.; Srinath, S.; Girimaji, S.; Seshadri, S.P. 2004: Citalopram and mania. Journal of the American Academy of Child and Adolescent Psychiatry 43(7): 791
Callado, L.F.; Stamford, J.A. 2000: Citalopram and paroxetine increase noradrenaline efflux in the rat Locus Coeruleus Voltammetric data. Methods and Findings in Experimental and Clinical Pharmacology 22(6): 492
Lamps, C.A. 2002: Citalopram and psychotic symptoms. Journal of the American Academy of Child and Adolescent Psychiatry 41(1): 6
Hadi, F.; Franco, K.; Hermida, T.; Douton, K.; Zarko, R. 2003: Citalopram for impulsive aggression. Journal of the American Academy of Child and Adolescent Psychiatry 42(7): 749; Author Reply 749-50
Schaefer, M.; Schwaiger, M.; Berg, T. 2003: Citalopram for prevention of interferon-alpha associated depression in psychiatric risk patients. Hepatology 38(4 Suppl 1): 320A
Bostic, J.O.; Prince, J.; Brown, K.; Place, S. 2001: Citalopram for the treatment of adolescent depression. Pediatric Research 49(4 Part 2): 455A
Veendrick, M.J.B.; Aldenkamp, A.P.; Tan, I.Y. 2004: Citalopram in mentally retarded epilepsy patients with anxiety disorder. Epilepsia 45(Suppl 3): 166
Del Ben, C.M.; Delvai, N.A.; Richardson, P.; Williams, S.; Mckie, S.; Elliott, R.; Anderson, I.M.; Deakin, J.W.F. 2003: Citalopram modulates brain activation in response to implicit recognition of facial expressions. Journal of Psychopharmacology 17(Suppl 3): A15
Tarabar, A.F.; Hoffman, R.S.; Nelson, L.S. 2003: Citalopram overdose Late presentation of torsades de pointes with cardiac arrest. Journal of Toxicology. Clinical Toxicology 41(5): 676
Balldin, J.; Berggren, U.; Blennow, K.; Eriksson, M.; Fahlke, C. 2000: Citalopram transiently reduce alcohol consumption in subjects with the DRD2 A2/A2 allele. Alcoholism Clinical and Experimental Research 24(5 Suppl): 37A
Flicker, C.; Gottfries, C.G.; Overo, K.; Lundbeck, H. 1999: Citalopram treatment of depression in elderly patients with or without dementia Results of a placebo-controlled trial. Journal of the American Geriatrics Society 47(9): S87
Rosenberg, C.; Petersen, H.E.H.pfner 2000: Citalopram versus amitriptyline in elderly patients with or without dementia A Danish multicentre trial in general practice. European Neuropsychopharmacology 10(Suppl 3): S278
Sachdev, P. 2002: Citalopram-Clonazepam combination for primary depersonalization disorder: a case report. Australian and New Zealand Journal of Psychiatry 36(3): 424-425
Fisher, A.; Davis, M.; Croft-Baker, J.; Purcell, P.; McLean, A. 2002: Citalopram-induced severe hyponatraemia with coma and seizure. Case report with literature and spontaneous reports review. Adverse Drug Reactions and Toxicological Reviews 21(4): 179-187
Lanska, D.J. 1999: Citation classics of 19th century American neurologic pioneers. Neurology 52(6 Suppl 2): A69
Conn, P.Michael 2004: Citation for the 2004 Clinical Investigator Award Lecture of The Endocrine Society to Dr Shlonto Melmed. Journal of Clinical Endocrinology and Metabolism 89(8): 4174-4175
Smith, M.Susan 2004: Citation for the 2004 Roy O Greep Award Lecture of The Endocrine Society to Dr Phyllis M Wise. Endocrine Reviews 25(4): 687-688
Jameson, J.Larry 2004: Citation for the 2004 Sidney H Ingbar Distinguished Service Award of The Endocrine Society to Dr Margaret A Shupnik. Endocrine Reviews 25(4): 686-687
Lehmann, E.D. 2001: Cited "validation" references for the SphygmoCor device. Kidney International 59(4): 1597-1598
Sparrow, D.B.; Withington, S.L.; Scott, A.N.; Preis, J.; Rodriguez, T.; Beddington, R.S.P.; Dunwoodie, S.L. 2003: Cited1 is required for normal placental development in mouse. Developmental Biology 259(2): 558
Boyle, Scott; Shioda, Toshi; De Caestecker, Mark P. 2003: Cited1 specifies diverse cell fates within the developing kidney. Journal of the American Society of Nephrology 14(Abstracts Issue): 101A
Hoshino, K.; Amaoka, K. 1999: Citharichthys gnathus, a new species of paralichthyid flounder from the Galapagos Islands, eastern Pacific Ocean. Ichthyological Research 46(4): 371-375
Killgore, W.D.S.; Ross, A.J.; Kamiya, T.; Kawada, Y.; Renshaw, P.F.; Yurgelun-Todd, D.A. 2010: Citicoline affects appetite and cortico-limbic responses to images of high-calorie foods. International Journal of Eating Disorders 43(1): 6-13
Adibhatla, R.M.; Hatcher, J.F.; Dempsey, R.J. 2003: Citicoline attenuates phospholipase A2 activation and hydroxyl radical generation in transient cerebral ischemia. Journal of Neurochemistry 85(Suppl 1): 9
Adibhatla, R.M.; Hatcher, J.F.; Dempsey, R.J. 2003: Citicoline attenuates phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia. Journal of Neurochemistry 87(Suppl 1): 144
Cardenas, A.; De Cristobal, J.; Castillo, J.; Davalos, A.; Leza, J.C.; Moro, M.A.; Lorenzo, P.; Lizasoain, I. 2002: Citicoline is neuroprotective by reducing glutamate levels after permanent focal cerebral ischemia in rats. British Journal of Pharmacology 135(Proceedings Suppl): 351P
Makarewicz, D.; Grieb, P. 2003: Citicoline markedly attenuates hypoxic-ischemic brain damage in neonatal rats. Journal of Neurochemistry 87(Suppl 1): 134
Goulis, D.G.; Giaglis, G.D.; Tsimtsiou, Z.; Kontopoulos, M.; Moraiti, A.; Kita, M.; Maglaveras, N.; Avramides, A. 2003: Citizen Health Care A randomized control-matched trial for home-centred management in obese patients. International Journal of Obesity 27(Suppl 1): S107
Goulis, D.G.; Tsimtsiou, Z.; Giaglis, G.D.; Kontopoulos, M.; Moraiti, A.; Kita, M.; Maglaveras, N.; Avramides, A. 2003: Citizen Health Care An EU programme for integrated, home-entred management for patients with obesity. International Journal of Obesity 27(Suppl 1): S107
Jackson, J. 2000: Citizen activists and scientists A symbiotic relationship. IAGLR Conference Program and Abstracts 43: A - 68
Sarnelle, O.; Morrison, J.; Kaul, R.; Horst, G.; Wandell, H.; Bednarz, R. 2010: Citizen monitoring: Testing hypotheses about the interactive influences of eutrophication and mussel invasion on a cyanobacterial toxin in lakes. Water Research 44(1): 141-150
D.Silva, A.F. 2003: Citizen participation in the preservation and restoration of the Southern Tip of Lake Michigan. IAGLR Conference Program and Abstracts 46: 163-164
Prysby, M.D. 2003: Citizen scientists contribute to education and research in Great Smoky Mountains National Park. Ecological Society of America Annual Meeting Abstracts 88: 273-274
Einsiedel, E. 2002: Citizen verdicts on xenotransplantation in Canada. AAAS Annual Meeting and Science Innovation Exposition 168: A50, 14-19 February
Martin, A.; Dellasala, D.A.; Schulke, T.; Bird, B.; Criley, M.; Van Daalen, C.; Kreilick, J.; Brown, R. 2002: Citizens call for ecological forest restoration Forest restoration principles and criteria. Ecological Society of America Annual Meeting Abstracts 87: 203
Hoerr, B. 2003: Citizens; an essential part of sustainable lake management programs. IAGLR Conference Program and Abstracts 46: 36
Risueno, C.; Capriles, M.; Orellana, E.; Alvarez, M.G. 1999: Citokeratin 20 as a marker for early detection of disseminated tumor cells from gastrointestinal cancers by reverse transcription PCR. Proceedings of the American Association for Cancer Research 40: 712
Carvalho, E.M.; Porto, A.F.; Bacelar, O.; Dutra, W.O.; Carvalho, L.P.; Neva, F.; Gollob, K.J. 2001: Citokine profile and immunomodulation in asymptomatic HTLV-1 infected blood donors. AIDS Research and Human Retroviruses 17(Suppl 1): S 27
Alarcon Zurita, Antonio; Munar, Maria A.; Losada, Patricia G.; Morey, Antonio; Martinez, Josefa; De La Prada, Francisco J.; Marco Franco, Julio E.; Romero, Ramon 2001: Citomegalovirus infection after renal transplantation Revision of three different protocols. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 875A
Alcantara Gonzalez, N.A.; Medel Flores, O.; Carlos Reyes, M.A.; Rivera Orduna, F.N.; Garcia Carrizales, S.; Ortiz Austin, A.; Borja Cacho, E.; Zepeda Lopez, H.M. 1999: Citoskeletal rearrangement in vivo by enterotoxigenic Escherichia coli. Abstracts of the General Meeting of the American Society for Microbiology 99: 63
Taramelli, D.; Brambilla, S.; Riviera Uzielli, L.; Bruccoleri, A.; Leopardi, O.; Boelaert, J.R. 1999: Citotoxic activity of human and mouse phagocytes against Penicillium marneffei Role of cytokines and iron. European Journal of Clinical Investigation 29(Suppl 1): 47
Uribe Hernandez, R.; Perez Zapata, A.J. 2003: Citotoxicity and oxidative stress induced by polycyclic aromatic hydrocarbons in human leukocytes. Toxicology Letters (Shannon) 144(Suppl 1): s118
Tanaka, S.; Tanaka, S.; Akiba, S.; Ara, K.; Ishida, H. 2003: Citral acetal. Official Gazette of the United States Patent and Trademark Office Patents 1266(2)
Mei, L.; Choi, S.J.; Alamed, J.; Henson, L.; Popplewell, M.; McClements, D.J.; Decker, E.A. 2010: Citral stability in oil-in-water emulsions with solid or liquid octadecane. Journal of Agricultural and Food Chemistry 58(1): 533-536
Medrano, J.A.; Pena, A.; Rigau, T.; Rodriguez Gil, J.E. 2003: Citrate and lactate as feasible energy sources for boar spermatozoa. Reproduction in Domestic Animals 38(4): 340
Caudarella, R.; Vescini, F.; Buffa, A.; Stefoni, S. 2003: Citrate and mineral metabolism: kidney stones and bone disease. Frontiers in Bioscience: a Journal and Virtual Library 8: S1084-S1106
Hering Smith, K.S.; Hamm, L.L. 2000: Citrate and succinate transport in polarized OK proximal tubule cells. FASEB Journal 14(4): A354
Delvecchio, F.C.; Brizuela, R.M.; Byer, K.J.; Springhart, W.P.; Zhong, P.; Khan, S.R.; Preminger, G.M. 2004: Citrate and vitamin E blunt the SWL-induced free radical surge in an in-vitro MDCK cell culture model. Journal of Urology 171(4 Suppl): 295
Herget Roseuthal, S.; Lison, C.; Treichel, U.; Saner, F.; Pietruck, F.; Broelsch, C.; Gerken, G.; Philipp, T.; Kribben, A. 2003: Citrate anticoagulated modified fractionated plasma separation and adsorption First clinical efficacy and safety data in liver failure. Journal of the American Society of Nephrology 14(Abstracts Issue): 729A
Unver, B.; Buchmayer, H.; Sunder Plassmann, G.; Horl, W.H.; Apsner, R. 2000: Citrate anticoagulation during high flux hemodialysis 1009 dialyses in 59 patients. Kidney and Blood Pressure Research 23(3-5): 303
Vanderford, P.A.; Chorman, T. 2001: Citrate anticoagulation for CRRT in children. Blood Purification 19(3): 339
Mehta, R.L.; Pascual, M.T.; Zhuang, S. 2000: Citrate anticoagulation for continuous renal replacement therapy An update. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 325A
Calatzis, A.; Toepfer, M.; Schramm, W.; Spannagl, M.; Schiffl, H. 2001: Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron 89(2): 233-236
Johnson, P.M.; Maxvold, N.J.; Bunchman, T.E. 2001: Citrate anticoagulation for pediatric CRRT. Blood Purification 19(3): 341
Dorval, M.; Madore, F.; Geadah, D.; Leblanc, M. 2002: Citrate anticoagulation monitoring Post-filter act or ionized calcium?. Blood Purification 20(3): 312
Poirier, M.; Harvey, D.; Corbin, M.P.; Vincent, G.; Des Rosiers, C. 1999: Citrate cataplerosis and its link to malonyl-CoA synthesis in the perfused rat heart. FASEB Journal 13(5 Part 2): A764
Hombrouckx, R.; De Vos, J.Y. 2001: Citrate dialysis Adverse effects. International Journal of Artificial Organs 24(8): 534
Okamura, K.; Harada, Y.; Tai, S. 2003: Citrate facilitates postexercise hepatic glycogen repletion in fructose-ingested rats. FASEB Journal 17(4-5): Abstract 199
Wentworth, D.W.; Kim, F.J.; Lentino, J.R.; Hatch, D.A.; Gandhi, V.C.; Kjellstrand, C.M.; Ing, T.S. 1999: Citrate may be the anticoagulant of choice to prevent clotting of antibiotic locks used in vascular access devices. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 222A
Kramer, L.; Bauer, E.; Joukhadar, C.; Strobl, W.; Gendo, A.; Madl, C.; Gangl, A. 2003: Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Critical Care Medicine 31(10): 2450-2455
Bisson, N.P.; Taylor, G.J. 2002: Citrate release is associated with the induction of aluminum resistance in Phaseolus vulgaris L. Plant Biology (Rockville) : 185
Johnson, P.J.; Rose, P.R.; Williams, G.R.; Wint, L.T. 2004: Citrate salt of 5,8,14-triazatetracyclo -hexadeca-2 ,3,5,7,9-pentaene and pharmaceutical compositions thereof. Official Gazette of the United States Patent and Trademark Office Patents 1286(1)
Gutilla, M.J.; Mattern, C.O.; Bright, D.L.; Devor, S.T. 2003: Citrate synthase activity does not decline with age in highly aerobically trained athletes. Medicine and Science in Sports and Exercise 35(5 Suppl): S213
Quintela, E.; Newcomer, S.C.; Leek, B.; Richardson, R.S. 2000: Citrate synthase activity in skeletal muscle Response to acute exercise. Medicine and Science in Sports and Exercise 32(5 Suppl): S320
Cekic, C.; Ozdogan, S.; Kocabiyik, S. 2003: Citrate synthase from Thermoplasma volcanium and construction of its fusion products. Molecular and Cellular Proteomics 2(9): 894
Danson, M.J.; Hough, D.W. 2001: Citrate synthase from hyperthermophilic Archaea. Methods in Enzymology 331: 3-12
Greene, H.M.; Wickler, S.J.; Mccaffray, T.N. 1999: Citrate synthase, HOAD and LDH in equine skeletal muscle after acute acclimatization to 3800 meters. FASEB Journal 13(5 Part 2): A785
Hering Smith, K.S.; Gambala, C.; Pajor, A.M.; Dauterive, C.; Hamm, L.L. 1999: Citrate transport characteristics in proximal tubule cell culture model. FASEB Journal 13(4 Part 1): A60
Land, M.; Andersen, L.; Andrews, L.; Bendiak, D.; Cameron Clarke, A.; Hammel, C.; Jibiki, M.; Kelly, G.; Lodolo, E.; Pugh, T.; White, L.; Dull, C.L. 2001: Citrate-buffered methylene violet stain as an alternative to conventional stains used to determine yeast viability. Journal of the American Society of Brewing Chemists 59(4): 232-233
Kruger, L.; Andersen, L.; Barbero, F.; Bendiak, D.; Carvell, J.; Foley, T.; Gonzalez, G.; Hulse, G.; Pili, G.; Pirez, G.; Pugh, T.; Smart, K.; Stewart, R.; Teass, H.; Vargas, G.; Wallace, L.; White, C.; Wright, G.; Dull, C.L. 2000: Citrate-buffered methylene violet stain for yeast viability. Journal of the American Society of Brewing Chemists 58(4): 178-179
Reddy,N.; Yang,Y. 2010: Citric acid cross-linking of starch films. Food Chemistry 8(3): 702-711
Vinarov, A.; Dorochov, I. 1999: Citric acid crystallization process Experimental investigation and modelling. Mededelingen van de Faculteit Landbouwwetenschappen - Rijksuniversiteit Gent 64(5B): 651-653
Shiotani, A.; Saeed, M.A.; Yamaoka, Y.; El Zimaity, H.M.T.; Osato, M.S.; Klein, P.D.; Graham, D.Y. 2000: Citric acid enhanced gastric urease activity in man is unrelated to gastric emptying. Gut 47(Suppl 1): A120
Nagai, R.; Nagai, M.; Shimasaki, S.; Baynes, J.W.; Fujiwara, Y. 2010: Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats. Biochemical and Biophysical Research Communications 393(1): 118-122
Aurich, A.; Foerster, A.; Mauersberger, S.; Barth, G.; Stottmeister, U. 2003: Citric acid production from renewable resources by Yarrowia lipolytica. Biotechnology Advances 21(5): 454-455
Nagoba, B.S.; Wadher, B.J.; Chandorkar, A.G. 2002: Citric acid treatment of non-healing ulcers in leprosy patients. British Journal of Dermatology 146(6): 1101
Slone, C.S.; Lassila, K.R.; Meier, I.K. 2002: Citric acid tri-alkylamide surfactants. Official Gazette of the United States Patent and Trademark Office Patents 1259(1)
Marshall, W.E.; Chatters, A.Z.; Wartelle, L.H.; Mcaloon, A.J. 2001: Citric acid-modified soybean hulls Process optimization and estimated cost of production. Abstracts of Papers American Chemical Society 221(1-2): ENVR 249
Grafton Cardwell, E.E.; Reagan, C.A. 1999: Citricola scale insecticide efficacy trial, 1997. Saxena, K N Arthropod Management Tests 90
Sang, S.; He, K.; Liu, G.; Zhu, N.; Wang, M.; Jhoo, J.W.; Zheng, Q.; Dong, Z.; Ghai, G.; Rosen, R.T.; Ho, C.T. 2001: Citrifolinin A, a new unusual iridoid with inhibition of Activator Protein-1 from the leaves of noni. Tetrahedron Letters 42(10): 1823-1825, 4 March
Newman, J.V.; Dangler, C.A.; Jha, S.S.; Schauer, D.B. 2000: Citrobacter rodentium infection promotes colon tumorigenesis in Apc mice. Proceedings of the American Association for Cancer Research 41: 736
Storet, I. 2002: Citronellyl and/or dihydrocitronellyl lactates, their preparation and their use. Official Gazette of the United States Patent and Trademark Office Patents 1263(1)
Lee, J.; Ellaway, C.; Kobayashi, K.; Wilcken, B. 2002: Citrullinaemia type II A rare cause of neonatal hepatitis detected by newborn screening. Journal of Inherited Metabolic Disease 25(Suppl 1): 29
Lutgens, L.C.H.W.; Deutz, N.E.P.; Gueulette, J.; Von Meyenfeldt, M.F.; Lambin, P. 2000: Citrulline A quantitative marker for epithelial small bowel radiation injury An experimental study in mice. Radiotherapy and Oncology 56(Suppl 1): S15-S16
Akashi, K.; Miyake, C.; Kohchi, T.; Yokota, A. 2001: Citrulline functions as the efficient hydroxyl radical scavenger Implication for the drought-tolerance of wild watermelon plant. Photosynthesis Research 69(1-3): 170
Keilhoff, G.; Wolf, G. 2000: Citrulline immunostaining A useful approach to demonstrate NOS activity at the single cell level. Nitric Oxide 4(3): 264
Vilaseca, M.A.; Kobayashi, K.; Briones, P.; Lambruschini, N.; Campistol, J.; Tabata, A.; Alomar, A.; Rodes, M.; Lluch, M.; Saheki, T. 2000: Citrullinemia Clinical presentation, evolution and molecular analysis of five Mediterranean cases. Journal of Inherited Metabolic Disease 23(Suppl 1): 56
Maruyama, H.; Ogawa, M.; Nishio, T.; Kobayashi, K.; Saheki, T.; Sunohara, N. 2001: Citrullinemia type Ii in a 64-year-old man with fluctuating serum citrulline levels: mutations in the SLC25A13 gene. Journal of the Neurological Sciences 193(1): 63
Gottwald, T.R.; Schubert, T.S. 2002: Citrus canker Plant pathology versus public policy. Phytopathology 92(6 Suppl): S31
Minagawa, A.; Otani, Y.; Kubota, T.; Kitajima, M. 2001: Citrus flavonoid inhibits the experimental peritoneal dissemination of human gastric carcinoma in severe combined immunodeficient mouse through matrix metalloproteinase inhibition. Proceedings of the American Association for Cancer Research 42: 947
Datla, K.P.; Christidou, M.A.; Widmer, W.W.; Rooparai, H.K.; Dexter, D.T. 2002: Citrus flavonoid tangeretin accumulates in the brain and pre-treatment protects against dopaminergic neuronal loss in a rat model of Parkinsons disease. British Journal of Pharmacology 135(Proceedings Suppl): 350P
Datla, K.; Christidou, M.A.; Widmer, W.W.; Dexter, D.T. 2002: Citrus flavonoid tangeretin protects against dopaminergic neuronal loss in a rat model of Parkinsons disease. Abstracts of Papers American Chemical Society 224(1-2): AGFD 4
Hiramoto, T.; Saiki, K.; Masumura, S.; Shimizu, T.; Yamashita, T. 2002: Citrus flavor having high stability, method of preparation thereof and food and drink product containing said flavor. Official Gazette of the United States Patent and Trademark Office Patents 1265(3)
White, D.P.; Vandenberg, T.; Freeman, D.J.; Guthrie, N. 2000: Citrus juice components induce apoptosis in MDA-MB 435 estrogen receptor negative cells. FASEB Journal 14(4): A474
Davis, C.L.; Thomas, M.; Pao, S.C.iang 2004: Citrus juice vesicle separation method and system. Official Gazette of the United States Patent and Trademark Office Patents 1285(4)
Dresser, G.K.; Schwarz, U.I.; Leake, B.; Choo, E.F.; Wilkinson, G.R.; Bailey, D.G.; Kim, R.B. 2001: Citrus juices are potent inhibitors of intestinal OATP but not P-glycoprotein. Clinical Pharmacology and Therapeutics 69(2): P23
Bastianel,M.; Novelli,V.M.; Kitajima,E.W.; Kubo,K.S.; Bassanezi,R.B.; Machado,M.A.; Freitas-Astua,J. 2010: Citrus leprosis centennial of an unusual mite-virus pathosystem. Plant Disease: 3, 284-292
Miller, E.G.; Taylor, S.E.; Berry, C.W.; Zimmermann, J.A.; Hasegawa, S. 1999: Citrus limonoids Increasing potential as anticancer agents. Abstracts of Papers American Chemical Society 217(1-2): AGFD 54
Tanaka, T.; Ota, T.; Miyake, M.; Wada, K. 1999: Citrus limonoids obakunone and limonin inhibit the development of a precursor. Abstracts of Papers American Chemical Society 217(1-2): AGFD 56
Hakim, I.A.; Harris, R.B.; Ritenbaugh, C. 2000: Citrus peel intake and squamous cell carcinoma of the skin. Proceedings of the American Association for Cancer Research 41: 37
Hakim, I.A.; Harris, R.B. 2001: Citrus peel use and black tea intake are independently associated with reduced risk of squamous cell carcinoma of the skin. Proceedings of the American Association for Cancer Research 42: 20
Lioutas, T.S.; Chu, O. 2000: Citrus products incorporating pulp processing. Official Gazette of the United States Patent and Trademark Office Patents 1233(4)
Akimitsu, K.; Ohtani, K.; Gotoh, Y.; Nalumpang, S.; Isshiki, A.; Gomi, K.; Yamamoto, H. 2001: Citrus responses to a pathogenicity factor The brown spot disease caused by the rough lemon pathotype of Alternaria alternata. Keen, Noel T , Reprint Author, Mayama, Shigeyuki, Leach, Jan E, Tsuyumu, Shinji Delivery and perception of pathogen signals in plants: 202-211
Mello,A.F.S.; Yokomi,R.K.; Melcher,U.; Chen,J.C.C.; Fletcher,J. 2010: Citrus stubborn severity is associated with Spiroplasma citri titer but not with bacterial genotype. Plant Disease: 1, 75-82
Melzer, M.J.; Hu, J.S. 2002: Citrus trizteza virus incidence and diversity in Hawaii as detected by molecular and serological assays. Phytopathology 92(6 Suppl): S151
Morgan, K.T.; Wheaton, T.A.; Parsons, L.R.; Scholberg, J.M.; Obreza, T.A. 2001: Citrus water use model for Florida fine sand soils. HortScience 36(3): 611
Krasny,M.E.; Tidball,K.G. 2010: Civic ecology linking social and ecological approaches in extension. Journal of Extension: 1, 1iaw 1
Porter, C.R.; Sotelo, T. 2001: Civil War bladder calculi Their etiology and treatment. Journal of Urology 165(5 Suppl): 179
Gruen, M.B.; Ko, K.; Nosko, M.G. 1999: Civil war head injury and twentieth-century treatment. Journal of Trauma 47(1): 151-153
Altshuler, B.; Reynolds, J.F. 2004: Civilian anti-terrorist attack gas mask. Official Gazette of the United States Patent and Trademark Office Patents 1283(4)
Farre, A.J.; Frigola, J. 2002: Cizolirtine citrate Analgesic. Drugs of the Future 27(8): 721-732
Morris, M.C.; Reed, S.I. 2001: Cks1 is required for the timely regulation of CDC28 phosphorylation/dephosphorylation in the morphogenesis checkpoint of S cerevisiae. Cell Biology International 25(2): A22
Gualberto, A.; Obejero Paz, C.A.; Muro Cacho, C.; Hixon, M.L.; Wagner, M.W.; Hassold, T.; Nagy, J.K.; Millie, E.A. 1999: Cks1 mediates vascular smooth muscle cell polyploidization in primary and secondary forms of hypertension. Circulation 100(18): 1; 704
Attaya, E.N.; Ravnik, S.E. 2002: Cks2 is upregulated during meiosis and binds the meiotic isoform, Cdk2beta. Journal of Andrology Suppl (Suppl): 31
O'connor, K.R.; Beyenbach, K.W. 2000: Cl channels in apical membrane patches of stellate cells of insect Malpighian tubules. FASEB Journal 14(4): A109
Brown, P.D.; Kajita, H.; Majid, A.; Speake, T. 2000: Cl- channel expression in choroid plexus epithelial cells. Journal of Korean Medical Science 15 Suppl: S10-S11
Garber, S.S.; Messerli, M.A.; Hammer, K.; Hubert, M.D.; Indyk, E.; Smith, P.J.S. 2003: Cl- flux during cell volume regulation recorded using modulation of ion-selective electrodes. Journal of General Physiology 122(1): 33a
Pilkington, M.; Thorn, P. 2003: Cl- secretion in intact acinar cells A role for the Na+-K+-2Cl- cotransporter. Biophysical Journal 84(2 Part 2): 83a-84a
Abdulnour Nakhoul, S.; Imeryuz, N.; Orlando, R.C. 1999: Cl- transport properties of the apical and basolateral membranes of rabbit esophageal epithelial cells. Gastroenterology 116(4 Part 2): A106
Liu, B.; Hattori, N.; Jiang, B.; Inagaki, C. 2003: Cl--ATPase activity in immune cells. Journal of Pharmacological Sciences 91(Suppl I): 225P
Inagaki, C.; Hattori, N.; Kitagawa, K.; Zeng, X.T.; Yagyu, K. 2000: Cl--ATPase in rat brain neurons. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 126A(Suppl 1): S71
Jiang, Z.; Rudnick, H.; Aronson, P.S. 2003: Cl-base exchange mediated by SLC26A6 in opossum kidney cells. Journal of the American Society of Nephrology 14(Abstracts Issue): 314A
Jackson, W.F. 2000: Cl-channel blockers dilate O2 constricted arterioles in the hamster cheek pouch. FASEB Journal 14(4): A31
Banerjee, S.R.; Levaladala, M.K.; Zubieta, J.; Babich, J.W. 2002: Cl3 core complexes with potential bifunctional chelators constructed from amino acids and analogues. Abstracts of Papers American Chemical Society 224(1-2): INOR 205
Mummery, J.L.; Killey, J.; Linsdell, P. 2004: ClC chloride channels in human submucosal gland serous cells Implications for Cystic Fibrosis lung disease. FASEB Journal 18(4-5): Abstract 216
Cuppoletti, J.; Sherry, A.M.; Malinowska, D.H. 2000: ClC-2 Cl- channel is present in gastric parietal cells. FASEB Journal 14(4): A334
Cuppoletti, J.; Sherry, A.M.; Malinowska, D.H. 2000: ClC-2 Cl- channels in the epithelia as targets for therapy in cystic fibrosis. FASEB Journal 14(4): A334
Ranker, J.O.; Cuppoletti, J.; Melvin, J.E.; Shull, G.E.; Malinowska, D.H. 2004: ClC-2 Knockout Mice Exhibit Reduced Stimulated HCl Secretion. FASEB Journal 18(4-5): Abstract 456
Holmes, K.W.; Hales, R.; Chu, S.; Mogayzel, P.; Maxwell, M.J.; Zeitlin, P.L. 2003: ClC-2 chloride channel expression is developmentally regulated by Sp1 and Sp3. Pediatric Research 53(4 Part 2): 35A
Cid, L.P.; Niemeyer, M.I.; Sepulveda, F.V. 2000: ClC-2 chloride channel splice variants Possible regulation by phosphorylation. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 126A(Suppl 1): S28
Lipecka, J.; Fritsch, J.; Bali, M.; Torossi, T.; Brouillard, F.; Soumarmon, A.; Ostoja Zagorski, W.; Edelman, A. 1999: ClC-2 protein expression in cells and tissues. Journal of Physiology (Cambridge) 517P: 69P-70P
Hume, J.R.; Yamamoto Mizuma, S.; Wang, G.X.; Satterwhite, C.M.; Duan, D.; Britton, F.; Yamboliev, I.; Hatton, W.; Horowitz, B. 2003: ClC-3 and volume-regulated Cl- channels The minority report. Journal of General Physiology 122(1): 6a
Schmieder, S.; Lindenthal, S.; Idelson, G.; Ehrenfeld, J. 1999: ClC-3 chloride channel distribution in mammalian tissue. Journal of Physiology (Cambridge) 517P: 15P
Moreland, J.G.; Nauseef, W.M.; Davis, A.P.; Bailey, G.; Lamb, F.S. 2004: ClC-3 chloride channel is involved in generation of the respiratory burst by stimulated leukocytes. FASEB Journal 18(4-5): Abstract 776
Wang, L.; Chen, L.; Jacob, T.J.C. 1999: ClC-3 contributes towards a proportion of volume-activated chloride currents and volume regulation in bovine ciliary epithelial cells. Journal of Physiology (Cambridge) 515P: 166P
Sanders, K.M.; Bradley, K.K.; Walker, R.L.; Horowitz, B.; Dick, G.M. 1999: ClC-3 in myocytes of the canine and human gastrointestinal tract. Biophysical Journal 76(1 Part 2): A404
Dickerson, L.W.; Weiss, R.M.; Bailey, M.C.; Lamb, F.S. 2002: ClC-3 knockout mice have left ventricular diastolic dysfunction. FASEB Journal 16(5): A822
Piwon, N.; Guenther, W.; Schwake, M.; Boesl, M.R.; Jentsch, T.J. 2001: ClC-5 Cl--channel disruption impairs endocytosis in a mouse model for Dents disease. Pfluegers Archiv European Journal of Physiology 441(6 Suppl): R180
Weng, T.; Mo, L.; Hellmich, H.L.; Wills, N.K. 2000: ClC-5 chloride channel expression in mammalian cells. Biophysical Journal 78(1 Part 2): 469A
Tanaka, K.; Hishikawa, K.; Nakaki, T. 2002: ClC-5 expression and albuminuria in spontaneously hypertensive rat are corrected by perindopril treatment. Japanese Journal of Pharmacology 88(Suppl 1): 209P
Hryciw, D.H.; Devuyst, O.; Guggino, W.B. 2002: ClC-5 is an essential component of the endoytic machinery in proximal tubule cells. FASEB Journal 16(5): A794
Sage, C.; Marcus, D.C. 2001: ClC-K chloride channel localization in strial marginal cells and vestibular dark cells of gerbil. FASEB Journal 15(5): A847
Christensen, E.I.; Devuyst, O.; Dom, G.; Nielsen, R.; Leruth, M.; Guggino, W.B.; Courtoy, P.J. 2002: ClC5 knock-out induces multiple alterations in the endocytic apparatus of proximal tubular cells. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 57A
Best, S.L.; Guo, Z.; Djuran, M.I.; Sadler, P.J. 1999: ClCl2 exchange phenomena observed by 1H and 13C NMR spectroscopy. Metal-Based Drugs 6(4-5): 261-270
Couri, M.S.; Pont, A.C. 2000: Cladistic analysis of Coenosiini. Systematic Entomology 25(3): 373-392
Johannesson, H.; Martin, M.P. 1999: Cladistic analysis of European species of Rhizopogon based on morphological and molecular characters. Mycotaxon 71: 267-283
Maher, B.S.; Devlin, B.; Marazita, M.L.; Vanyukov, M.M.; Ferrell, R.E. 2002: Cladistic analysis of MAOA haplotypes and association with the risk for attention deficit hyperactivity disorder. American Journal of Human Genetics 71(4 Suppl): 479
Vanyukov, M.M.; Maher, B.S.; Devlin, B.; Tarter, R.E.; Kirillova, G.P.; Ferrell, R.E. 2002: Cladistic analysis of MAOA haplotypes and association with the risk for substance use disorders. American Journal of Human Genetics 71(4 Suppl): 477
Sundberg, F.A. 2004: Cladistic analysis of early-Middle Cambrian kochaspid trilobites. Journal of Paleontology 78(5): 920-940
Rawson, P.D. 2002: Cladistic analysis of genetic differentiation between populations of the blue mussel, Mytilus trossulus. Journal of Shellfish Research 21(1): 394
Francois, J. 2003: Cladistic analysis of order Protura. Bulletin de la Societe Entomologique de France 108(2): 109-125
Chen Xiao Yong; Yang Jun Xing 2002: Cladistic analysis of the cyprinid subgenus Cyprinus fang. Zoological Research 23(3): 185-194
Lund, R.; Poplin, C. 2002: Cladistic analysis of the relationships of the Tarrasiids. Journal of Vertebrate Paleontology 22(3): 480-486, 19 September
Cox, P.G. 2004: Cladistic and functional comparative analysis of the orbital region of mammalian skulls. Journal of Morphology 260(3): 284
Razzaghi, H.; Aston, C.E.; Kamboh, M.I. 1999: Cladistic diplotype A novel method for organizing genotype data for statistical analysis. American Journal of Human Genetics 65(4): A395
Montreuil, O. 2000: Cladistic systematics of the genus Amphimallon. European Journal of Entomology 97(2): 253-270
Spagna, J.C.; Gillespie, R.G. 2001: Cladistics and biogeography of North American grass-spiders. American Zoologist 41(6): 1593
Bellan, G.L.; Bellan Santini, D.R. 1999: Cladistics as a tool for the ecomonitoring of the benthic communities in a stressed environment. American Zoologist 39(5): 33A
Molino Olmedo, Francisco 2001: Cladistics of genus Chiasognathus Stephens, 1831 with proposal of new subgenera. Elytron (Barcelona) 15: 119-128
Keller, R.A. 2000: Cladistics of the tribe Ectatommini A reappraisal. Insect Systematics and Evolution 31(1): 59-69
Morrone, J.J.; Acosta, R.; Gutierrez, A.L. 2000: Cladistics, biogeography, and host relationships of the flea subgenus Ctenophthalmus , with the description of a new Mexican species. Journal of the New York Entomological Society 108(1-2): 1-12
Romero Napoles, J.; Ayers, T.J.; Johnson, C.D.n 2002: Cladistics, bruchids and host plants Evolutionary interactions in Amblycerus. Acta Zoologica Mexicana 86: 1-16
Hollwedel, W.; Kotov, A.A.; Brandorff, G.O.tmann 2003: Cladocera from the Pantanal. Arthropoda Selecta 12(2): 67-93
Ketmaier, V.; Argano, R.; Cobolli, M.; De Matthaeis, E.; Messana, G. 1999: Cladogenetic events in two relict species of Stenasellidae from Sardinia Island A biochemical approach. Vie et Milieu 49(2-3): 93-99
Ahti, T.; Wirth, V.; Stenroos, S. 2001: Cladonia elixii, a new lichen species from New Zealand. McCarthy, P M Author, Kantvilas, G Author, Louwhoff, S H Journal J Author Bibliotheca Lichenologica Lichenological contributions in honour of Jack Elix 9-11
Diederich, P.; Van Den Boom, P.; Aptroot, A. 2002: Cladoniicola staurospora gen et sp nov, a new lichenicolous coelomycete from western Europe. Belgian Journal of Botany 134(2): 127-130
Vershinin, A.; Kamnev, A. 2001: Cladophora blooms at Anapa Beaches Result of anthropogenic eutrophication. Phycologia 40(4 Suppl): 45
Hiriart Baer, V.P.; Campbell, L.M.; Guildford, S.J.; Hecky, R.E.; Moore, L.; Charlton, M.N. 2003: Cladophora in Lake Ontario. IAGLR Conference Program and Abstracts 46: 120
Dixit, A.; Kwilinski, K. 2000: Cladosporium sphaerospermum A new allergenic species. Journal of Allergy and Clinical Immunology 105(1 part 2): S328
Moricca, S.; Ragazzi, A. 1999: Cladosporium tenuissimum antagonism to Cronartium flaccidum and Peridermium pini and its potential epidemiological significance. Journal of Plant Pathology 81(3): 235
Moricca, S.; Ragazzi, A.; Assante, G. 2001: Cladosporium tenuissimum, natural biocontrol agent of pine blister rust. Journal of Plant Pathology 83(3): 238
Ekrem, T. 1999: Cladotanytarsus bukavus comb n and C congolensis comb n from Central Africa. Annales de Limnologie 35(3): 185-191
Zypchen, L.N.; Nantel, S.H.; Barnett, J.; Noble, M.; Gascoyne, R.D.; Connors, J.M. 2003: Cladribine does not cure hairy cell leukemia. Blood 102(11): 437a
Rummel, M.J.; Chow, K.U.; Hoelzer, D.; Mitrou, P.S.; Jaeger, E.; Kaefer, G.; Mezger, J.; Westerhausen, M.; Schalk, K.; Hecker, R.; Karakas, T.; Fischer, M.; Bergmann, L. 2000: Cladribine plus mitoxantrone in the treatment of mantle-cell and low-grade lymphomas. Onkologie 23(Sonderheft 7): 151
Rodgers, V.D.; Younossi, Z.; Johnson, A.; Beutler, E. 1999: Cladribine treatment of refractory Crohns disease A prospective, randomized clinical trial. Gastroenterology 116(4 Part 2): A806
Graham, J.; Blennow, E.; Boavida, M.G.; Carter, N.; Cremer, C.; Cremer, T.; Delattre, O.; Gerdes, T.; Granum, E.; Hagemeijer, A.; Rivas, J.M. Hernandez; Kallioniemi, O.; Kirchhoff, M.; Kolvraa, S.; Lichter, P.; Pearson, P.; Philip, J.; Piper, J.; Van Der Ploeg, M. 2004: Claes Lundsteen - in memoriam. European Journal of Human Genetics 12(8): 603
Stempel, D.A.; Mclaughlin, T.; Yazdani, C.; Stanford, R.H. 2000: Claims analysis demonstrates that fluticasone propionate is associated with better clinical outcomes and significantly lower asthma care costs than montelukast. Chest 118(4 Suppl): 185S
Burdock, G.A.; Rowlands, J.C.aig 2003: Claims for functional food ingredients - a theory for regulatory approval. FASEB Journal 17(4-5): Abstract 458
Li, Q.; Sievert, T.R.; Brennan, P.J.; Besra, G.S.; Takayama, K. 2000: Claisen condensation in the synthesis of corynomycolic acids in Corynebacterium matruchotii Potentially effective target for new TB drugs. Tubercle and Lung Disease 80(2): 101
Srikrishna, A.; Kumar, P.P.aveen 2000: Claisen rearrangement based methodology for the spiroannulation of a cyclopentane ring Formal total synthesis of -acorone and isoacorones. Tetrahedron 56(41): 8189-8195, 6 October
Wallace, J.C. 1999: Clam farming and tourism A difficult combination? The socio-economic role of Ruditapes decussatus cultivation in the algarve. Journal of Shellfish Research 18(2): 730
Medeiros, Y.Araujo, C.; Brasileiro, I.L.G. 2000: Clam fishery in Brazil. Journal of Shellfish Research 19(1): 622
Mann, F.W.; Mann, K.W. 1999: Clam shell style large hay bale feeding apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1229(4)
Cooter, J. 2003: Clambus pallidulus Reitter in Herefordshire. Entomologist's Monthly Magazine 139(1670-1672): 185
Welch, R.Colin 2003: Clambus simsoni Blackburn from Yarner Wood, South Devon. Entomologist's Monthly Magazine 139(1670-1672): 190
Prance, D.A. 2002: Clambus simsoni Blackburn recorded from Middlesex. Entomologist's Monthly Magazine 138(1660-1663): 198
Mealy, N.E.; Martin, L.; Castaner, J. 2001: Clamikalant sodium Antiarrhythmic, KATP channel blocker. Drugs of the Future 26(10): 951-956
Smee, D.L.; Weissburg, M.J. 2003: Claming up Mercenaria reduce apparancy to whelk predators via waterborne chemical cues. Ecological Society of America Annual Meeting Abstracts 88: 310
Andersson,I.; Niedomysl,T. 2010: Clamour for glamour? City competition for hosting the Swedish tryouts to the Eurovision Song Contest. Tijdschrift Voor Economische En Sociale Geografie 1(2): 111-125
Malecki, W.W.; Sterman, W.D.; Gifford, H.S.IIi; Miller, S.H. 2002: Clamp assembly and method of use. Official Gazette of the United States Patent and Trademark Office Patents 1257(2)
Martinelli, O.; Inauen, B.; Fluhler, E.; Claes, L.E.; Gerngross, H.; Rubsaamen, G. 2002: Clamp assembly for an external fixation system. Official Gazette of the United States Patent and Trademark Office Patents 1259(4)
Bigliani, L.U.; Flatow, E.L.; Norman, D.L.; Vandiepenbos, J.A.; Yargosz, M. 2000: Clamp assembly for use with orthopaedic retractor frame assembly. Official Gazette of the United States Patent and Trademark Office Patents 1230(4)
Falls, J.W. 2003: Clamp device for orthopedic external fixator. Official Gazette of the United States Patent and Trademark Office Patents 1267(1)
Quah, E. 2003: Clamp device, method and system for exchanging a solution. Official Gazette of the United States Patent and Trademark Office Patents 1272(3)
Guala, G.; Guala, E. 2000: Clamp for closing flexible hoses of infusion transfusion and the like medical equipment. Official Gazette of the United States Patent and Trademark Office Patents 1241(3)
Sanfilippo, Dominic, J.II 2002: Clamp for vascular access device. Official Gazette of the United States Patent and Trademark Office Patents 1263(4)
Danitz, D.J.; Hegeman, D.E.; Buelna, T.J.; Gold, A.C. 2003: Clamp having bendable shaft. Official Gazette of the United States Patent and Trademark Office Patents 1269(2)
Jeruzalmi, D.; O'Donnell, M.; Kuriyan, J. 2002: Clamp loaders and sliding clamps. Current Opinion in Structural Biology 12(2): 217-224
Hermann, W. 1999: Clamping arrangements for an orthopedic fixation device and use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1228(3)
Cise, D.M.; Wood, S.M. 2004: Clamping assembly for maintaining the position of a respiratory care treatment device. Official Gazette of the United States Patent and Trademark Office Patents 1279(2)
Spitzer, D. 2000: Clamping connection for medical equipment and apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1231(2)
Lin, C.I.; Nichols, D. 2002: Clamping connector for spinal fixation systems. Official Gazette of the United States Patent and Trademark Office Patents 1260(1)
Gray, Bruce Nathaniel 2000: Clamping device. Official Gazette of the United States Patent and Trademark Office Patents 1238(3)
Tsai, A. 2003: Clamping tool for use in the maintenance of frameless eyeglasses. Official Gazette of the United States Patent and Trademark Office Patents 1272(3)
Howell, G.H.; Johnson, S.W.yne 2000: Clamping wing for catheter introducer. Official Gazette of the United States Patent and Trademark Office Patents 1239(5)
Bosch, X. 1999: Clams cause hepatitis A outbreak in Spain. Lancet (North American Edition) 354(9190): 1618
Messing, K.; Wohlgemuth, J.; Bencini, R. 2004: Clamshell distal catheter assembly. Official Gazette of the United States Patent and Trademark Office Patents 1282(2)
Cambra, I.; Garcia, F.J.; Martinez, M. 2010: Clan CD of cysteine peptidases as an example of evolutionary divergences in related protein families across plant clades. Gene 449(1-2): 59-69
Cvetkovic, D.; Serebriliakii, I.; Kotova, E.; Tricoli, J.V. 2001: Clar1 Expression in prostate cancer and potential role in signal transduction. Proceedings of the American Association for Cancer Research 42: 679-680
Broeckaert, F.; Clippe, A.; Knoops, B.; Hermans, C.; Bernard, A. 2000: Clara cell secretory protein Features as a peripheral lung biomarker. Mukherje, Anil B , Chilton, Beverly S Annals of the New York Academy of Sciences The uteroglobin/Clara cell protein family 68-77
Khedkar,G.D.; Reddy,A.C.S.; PersisMann; KondadhasulaRavinder; KshitishMuzumdar 2010: Clarias batrachus population is lacking genetic diversity in India. Molecular Biology Reports: 3, 1355-1362
Testi, M.; Angeloni, S.; Moscetti, A.; Valentini, T.; Mei, M.; Rosati, R.; Mariani, M. 2000: Clarification of HLA-A,B serologic ambiguous types by PCR-SSP in cord blood samples. Human Immunology 61(Suppl 1): S111
Marchal, R.; Lallement, A.; Jeandet, P.; Establet, G. 2002: Clarification of a Muscat must using a flotation technique and wheat gluten as fining agent. American Journal of Enology and Viticulture 53(3): 253A-254A
Goldstein, J.M.; Brecher, M. 2000: Clarification of anticholinergic effects of quetiapine. Journal of Clinical Psychiatry 61(9): 680
E.Z.maity, H.M.T.; Kim, J.G.; Graham, D.Y. 2001: Clarification of clinical relevance of gastric intestinal metaplasia. Gastroenterology 120(5 Suppl 1): A 607
Bahadur, G.; Ralph, D.; Hindmarsh, P. 2001: Clarification of consent. Fertility and Sterility 76(4): 852-853
Thomas, L.K.Jr 2000: Clarification of distance measurements in the random pairs and other plotless distance sampling methods. Bartonia 60: 75-79
Friedman, A.J. 2002: Clarification of efficacy!. Fertility and Sterility 78(4): 884
Gruzelier, J. 2001: Clarification of hemispheric modulatory influences on bilateral electrodermal activity, frontal asymmetry and mood. International Journal of Psychophysiology: Official Journal of the International Organization of Psychophysiology 41(2): 103-104
Chivers, M.L. 2001: Clarification of protein precipitate suspensions using anionic polymeric flocculants. Official Gazette of the United States Patent and Trademark Office Patents 1251(4)
Goldenring, J.R.; Kumar, R.; Navarre, J.; Lapierre, L. 2000: Clarification of recycling and endosome systems in using a dominant negative construct of myosin Vb, a downstream target of Rab11a. Journal of Investigative Medicine 48(2): 189A
Kadan, N.; Friedman, D.; Mertens, A.; Yusui, Y.; Whitton, J.; Robison, L.; Strong, L. 2001: Clarification of self-reported family history data by telephone interview. Proceedings of the American Association for Cancer Research 42: 884-885
Packer, D.L.; Peterson, L.A.; Monahan, K.H. 2002: Clarification of the course of the phrenic nerve in patients undergoing pulmonary vein isolation. Circulation 106(19): 2; 669
Kato, N.; Zhang, C.S.; Kenmoku, H.; Sassa, T. 2002: Clarification of the early-stage of the biosynthesis of fusicoccins and erinacines, the biologically active fungal diterpene glycosides, and the application to the creation of their novel derivatives. Nippon Nogeikagaku Kaishi 76(12): 1202-1205
Hedge, T.A.; Crouch, T.E. 1999: Clarification of the names Orthetrum julia falsum Longfield, 1955 and O julia capicola Kimmins, 1957. African Entomology 7(2): 302-304
Paggi, J.C. 2001: Clarification of the taxonomic status of Notodiaptomus anisitsi and related species, with description of a new species from Argentina. Hydrobiologia (453-454): 549-564, 15 June
Bodenbach, M.; Adam, P.; Kraft, K.; Müller-Hermelink, H.K.; Sparwasser, C. 2004: Clarification of tissue contamination in a suspected adenocarcinoma of the spermatic cord by microsatellite analysis. Der Urologe. Ausg. a 43(7): 845-847
Haase, Richard Alan 2000: Clarification of water and wastewater. Official Gazette of the United States Patent and Trademark Office Patents 1238(3)
Eggleston, G.; Grisham, M.; Antoine, A. 2010: Clarification properties of trash and stalk tissues from sugar cane. Journal of Agricultural and Food Chemistry 58(1): 366-373
Iyer, A.; Mistry, N.; Antia, N.; Harboe, M. 2000: Clarification to Rada-Schlaefli, et al. International Journal of Leprosy and other Mycobacterial Diseases: Official Organ of the International Leprosy Association 68(1): 63-64
Renn, D.W.; Blake, N.A. 2003: Clarified hydrocolloids of undiminished properties and method of producing same. Official Gazette of the United States Patent and Trademark Office Patents 1272(1)
Ohashi, S.; Shelso, G.J.; Drinkwater, W.L. 2000: Clarified konjac glucomannan. Official Gazette of the United States Patent and Trademark Office Patents 1241(3)
Merskey, H. 2002: Clarifying definition of neuropathic pain. Pain 96(3): 408-409
Gordon, M.; Burken, J.; Newman, L. 2003: Clarifying phytoremediation data. Environmental Science and Technology 37(17): 310a
Gonder, E. 2002: Clarifying poultry welfare issues. Journal of the American Veterinary Medical Association 221(6): 778-779
Max, M.B. 2002: Clarifying the definition of neuropathic pain. Pain 96(3): 406-407
Skapinakis, P.; Lewis, G.; Meltzer, H. 2003: Clarifying the relationship between unexplained chronic fatigue and psychiatric morbidity: results from a community survey in Great Britain. International Review of Psychiatry 15(1-2): 57-64
Heon, E.; Priston, M.K.; Billingsley, G.D.; Lubsen, N.H.; Munier, F.L. 1999: Clarifying the role of gamma crystallin in congenital CCL cataract. American Journal of Human Genetics 65(4): A19
Pfeiffer, D.G.; Killian, J.C.; Yoder, K.S. 1999: Clarifying the roles of white apple leafhopper and potato leafhopper in fire blight transmission in apple. Journal of Entomological Science 34(3): 314-321
International Commission, O.Zoological Nomenclature 2003: Clariidae Kutikova, Markevich Spiridonov, 1990 Spelling emended to Clariaidae so removing homonymy with Clariidae Bonaparte, 1846. Bulletin of Zoological Nomenclature 60(2): 149-150
Kutikova, L.A. 2001: Clariidae Kutikova, Markevich and Spiridonov, 1990 Proposed emendment of spelling to Clariaidae to remove homonymy with Clariidae Bonaparte, 1846. Bulletin of Zoological Nomenclature 58(4): 275-276
Gatta, L.; Figura, N.; Ricci, C.; D'anna, L.; Menegatti, M.; Perna, F.; Berardi, S.; Tampieri, A.; Holton, J.; Miglioli, M.; Vaira, D. 2001: Clarithromycin MICs level against Helicobacter pylori in pre and post treatment. Gastroenterology 120(5 Suppl 1): A 588
Niesvizky, R.; Bergsagel, P.L.; Pearse, R.N.; Pekle, K.A.; Lyons, L.M.; Cho, H.J.; Roboz, G.J.; Leonard, J.P.; Coleman, M. 2002: Clarithromycin Potentiates the Response to Dexamethasone in Chemotherapy Naive Multiple Myeloma Patients A Prospective, Sequential, Randomized Trial. Blood 100(11): Abstract No. 5119
Annese, V.; Bortolotti, M.; Fiorella, S.; Conoscitore, P.; Perri, F.; Andriulli, A. 2000: Clarithromycin accelerates gastric emptying by inducing powerful antral contractions. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A623
Vescio, R.A.; Sjak Shie, N.N.; Manyak, S.J.; Yang, H.; Berenson, J.R. 2001: Clarithromycin adds to the efficacy and toxicity of steroid therapy in multiple myeloma. Blood 98(11 Part 2): 312b-313b
Queiroz, D.M.M.; Cardinali, L.C.C.; Rocha, G.A.; Rocha, A.M.C.; Moura, S.B.; Soares, T.F.; Esteves, A.M.B.; Carvalho, A.S.T.; Ferreira, A.R.; Cabral, M.M.D.A.; Nogueira, A.M.M.F.; Bittencourt, P.F.S. 2002: Clarithromycin and metronidazole resistance of Helicobacter pylori strains isolated from Brazilian children. Gut 51(Suppl 2): A87
Nobata, K.; Ina, K.; Ohta, M.; Ando, T.; Kusugami, K. 2001: Clarithromycin at sub-minimal inhibitory concentration suppresses virulence factors of Helicobacter pylori. Gastroenterology 120(5 Suppl 1): A 587
Segura, F.; Antón, E. 2002: Clarithromycin for the treatment of Mediterranean spotted fever. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 34(4): 560